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1Small Scale Service Evaluation Project
Clinical Psychology Within A Psychiatric Ward
Prepared in accordance with guidelines fo r  submission to “Health Bulletin” 
(Appendix 1.1).
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3ABSTRACT
Objectives: To examine the function and need for clinical psychology within an in­
patient psychiatric setting and consequent future implications. Design: Survey of 20 
health professionals and assessment of 10 in-patients on two psychiatric wards, one of 
which received clinical psychology input and one that did not. Questionnaires 
established information regarding which of five health professions was most 
appropriate to complete and which profession was actually responsible for each of 24 
key activities. Projections were elicited for staffing requirements over the next 5 
years. Patients were assessed for identified factors relevant to predicting violence or 
self harm. Setting: Two in-patient psychiatric wards at a central Scotland psychiatric 
hospital. Results: Where clinical psychology services were provided, 7 of 24 
activities were seen as appropriate for clinical psychologists to complete. However 
only 2 activities were actually completed by clinical psychologists. Where there was 
no clinical psychology provision, staff views of what clinical psychology could 
provide was limited, e.g. IQ assessment. Staff on both wards predicted a need for a 
large increase in the provision of clinical psychology. Patient participants on both 
wards displayed symptomatology within a range that indicated psychological 
intervention. Conclusions: Staff questionnaires and assessment of patients identified 
a deficit in services, both in terms of meeting patient needs and in providing a more 
comprehensive clinical psychology service. It is unlikely that this deficit will be 
remedied quickly with the current difficulties in recruiting psychologists and the 
apparently limited knowledge of other health professionals and purchasers regarding 
what clinical psychologists can provide.
4INTRODUCTION
The low level of clinical psychology staffing in in-patient psychiatric settings is 
surprising for several reasons. These include the importance of psychological input 
and assessment in deciding who is suitable for admission or discharge, and the 
potential contributions of behavioural medicine and clinical therapy to effective client 
management and rehabilitation.
At the psychiatric hospital where this study was based, there was very little clinical 
psychology input to in-patient psychiatric wards, with the majority of the service 
being invested in primary care. However, what this indicated, confusion regarding the 
psychologist’s role or lack of knowledge about what clinical psychology can provide, 
was conjecture without further investigation.
In examining the function and definition of any role there are several important 
characteristics that should be considered: The organisation within which the role is 
based, the actual discipline itself and the client characteristics. Survey data from 
health professionals employed on the wards would enable us to look at the role of 
clinical psychology within the context of the hospital. In addition, evidence may be 
obtained from assessment of patient characteristics, as a psychologists role will 
change according to the needs of the patient population.
One of the most important patient characteristics (McGovern, 1996) that could 
respond to psychological intervention on in-patient psychiatric wards, is the likelihood
5of patients committing self harm or harm to others. This is of particular significance 
with the present government policy of returning individuals to live in the community 
(HMSO, 1975, 1989a & 1989b) where they may subsequently present a risk to 
themselves or others.
However, research at predicting this risk is at an early stage. There is conflicting 
evidence of the accuracy of clinicians ability to predict violence in patients, so it is 
vital that clinicians are aware of the most promising key areas. With regard to the 
harming of others, research has found associations between anger and physical 
aggression (Kay et al. 1988), physical assault (Novaco, 1994) and dangerousness to 
others (Segal et al. 1988).
The importance of impulsiveness in predicting risk of harm to others has also been 
investigated (Barratt, 1994). Looking at adults, students, offenders and psychiatric 
in-patients, Barratt found that psychiatric in-patients scored highest on “non planning 
impulsiveness” (i.e. lack of concern for the future). He hypothesised that this was 
part of a personality trait significantly related to aggression.
Research evidence for predicting risk of self harm is also available. Beck et al. (1985) 
reported that patients who committed suicide had significantly higher scores on the 
Beck Hopelessness Scale than non-suicidal patients when assessed during 
hospitalisation. The Beck Hopelessness Scale also has proven predictive value for 
identifying eventual suicides (Beck et al. 1985). Finally, Appleby (1992) reported the
6importance of features of affective disorders, particularly hopelessness, in suicide by 
psychiatric patients.
Using scales that measure anger, hopelessness and impulsiveness it may be possible to 
ascertain the degree to which patients are at risk of interpersonal violence or self 
harm, and then to consider this in reference to the role and functioning of clinical 
psychology services.
To conclude, the aims of this study were:
I To identify which professional group(s) was believed to be the most
appropriate to complete certain roles on the wards.
II To identify which professional group(s) was actually completing the above
mentioned roles.
III To identify what future pattern of growth was predicted in the requirement for
and actual provision of clinical psychology services over the next five years.
IV To identify a patient profile in the following personality factors:
a. Anger
b. Impulsiveness
c. Hopelessness
7SAMPLE
Hospital
This study was comprised of 2 in-patient wards. Ward A was a 20 bedded locked 
intensive psychiatric care ward. It did not receive any contracted clinical psychology 
services. Ward B was a 35 bedded acute admission ward. It received one contracted 
session of clinical psychology per week.
Staff
Forty seven questionnaires were delivered to health professionals on Wards A and B. 
All health care staff (41 nurses, 5 psychiatrists and 1 occupational therapist) providing 
a regular clinical service were invited to complete the study questionnaire.
Patients
Patients were selected at random by nursing staff. Only five were willing to 
participate from Ward A, so a corresponding number were invited to participate from 
Ward B, making a total of ten participants. Details of the participant sample are given 
in Table 1.
8Insert Table 1 here
Participant diagnoses on Ward A included schizophrenic psychoses, personality 
disorder and manic depression. Ward B participant admission diagnoses included 
alcohol dependence syndrome, depressive disorder and schizophrenic psychosis.
METHOD
Staff
Forty seven assessment packs were sent to respondents by internal mail, enclosing an 
addressed envelope for their return. A twenty item questionnaire was taken from 
Remenyi et al. (1981). The questionnaire was then modified by the author for this 
study, including the addition of four extra items, to make it more appropriate to the 
current client group. The visual analogue scales were designed by the current author.
9Respondents had to indicate on:
Questionnaire 1:
Which professional grouping(s) (Clinical psychologist, Nurse, Psychiatrist, 
Occupational Therapist (OT), Physician), where applicable, was most appropriate to 
have primary responsibility for each of 24 different professional activities on their 
ward (Appendix 1.2).
Questionnaire 2:
Which professional grouping(s) where applicable, actually had primary responsibility 
for the same activities on their ward (Appendix 1.3).
Ratings for other professions were obtained for comparison and so that respondents 
were not biased towards clinical psychology.
Visual Analogue Scale
Ratings were made on a visual analogue scale of 1-100. Estimates were made of what 
staffing would be needed in all health disciplines over the next five years. Estimates 
were also made of what staffing would actually be provided in all health disciplines 
over the next five years (Appendix 1.4).
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Patients
The following self report scales were used:
Brief Anger Aggression Questionnaire (BAAQ) (Maiuro et al. 1987).
A brief six item self report measure for the screening and assessment of overt anger 
and aggression levels in individuals who are prone to violence.
B arratt Impulsiveness Scale (BIS) (Barratt, 1994).
A thirty item self report scale which measures three distinct domains of impulsiveness. 
Beck Hopelessness Scale (BHS) (Beck and Steer, 1993).
A twenty item self-report questionnaire designed to measure hopelessness and suicidal 
risk.
RESULTS
Of the 47 questionnaires distributed, 20 were returned giving a response rate of 43%. 
Professions of respondents are detailed in Table 2. All were returned anonymously.
Insert Table 2 here
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It can be seen from Table 3 that assessing IQ was the only activity rated by staff as the 
most appropriate to be completed by a clinical psychologist on Ward A. Respondents 
from Ward B, which had psychological provision, identified seven activities as most 
appropriately completed by a clinical psychologist, including assessing IQ. This 
meant there was a marked difference of 6 activities that clinical psychologists were 
rated as appropriate to complete between Ward A and Ward B.
Insert Table 3 here
Table 4 describes the full list of activities that were viewed as most appropriately 
completed by other health professionals, instead of clinical psychology.
Insert Table 4 here
Nursing staff were rated as being the most appropriate to complete the majority of 
key activities on Ward A (63%) and Ward B (42%) (Table 5). In contrast clinical 
psychology was rated as being the most appropriate to complete only 4% of activities 
on Ward A and 29% of activities on Ward B.
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Clinical psychologists were identified as actually completing only 2 of 24 key activities 
(assessing IQ and therapeutic work with patient’s families) on Ward B (Table 6). 
Table 7 describes roles that were not completed by clinical psychologists on Ward B. 
Data is not provided for Ward A because it did not actually receive any psychological 
service. On both wards nursing staff were rated as actually completing the bulk of 
activities (Table 8).
Insert Tables 5,6,7 & 8 here
Table 9 shows that respondents predicted a need to increase clinical psychology 
services: a high rating of 85 on the scale of 1-100. This projected need was the 
greatest for any of the disciplines. Staff predicted that the actual increase in the 
provision of clinical psychology would be smaller though, rated 64 on the scale of 1- 
100.
Insert Table 9 here
This study also reviewed whether patients were exhibiting symptomatology that 
required psychological intervention and whether this need was being met, even where 
there was clinical psychology provision.
13
Insert Table 10 here
Table 10 illustrates that both Ward A and Ward B were accommodating patients 
within the severe range on all measures. Inferential statistics were not performed 
because of the small sample size.
DISCUSSION
Perceived Role o f clinical Psychology
Several issues were highlighted by this examination of clinical services. The first is 
regarding the perceived role of clinical psychologists within the NHS. It would seem 
that the perception of the traditional role of the clinical psychologist as IQ assessor is 
still prevalent. This was evidenced by the popularity of the IQ assessment item, 
although respondents from Ward B indicated a slight widening of role perspective by 
allocating 29% of all roles on the questionnaire as appropriate for clinical 
psychologists to complete.
IQ assessment was the only role rated as most appropriate to be completed by a 
clinical psychologist on Ward A. This may reflect a lack of knowledge about what
14
clinical psychology can offer, or it may be that clinical psychologists are still perceived 
in the traditional role of IQ assessors and lacking the requisite skills to undertake 
other activities.
Actual Role o f Clinical Psychology
With regard to ward B where 7 activities (29%) were identified as most appropriately 
completed by clinical psychologists, only two of these roles were actually completed 
by a clinical psychologist. This was possibly because of the limited time that clinical 
psychologists have on the ward. It may also be because of the failure of clinical 
psychologists to educate other professional staff and purchasers regarding their skills 
and thus the service they can provide. This meant that other staff, predominately 
nurses, were completing activities of a psychological nature, for which they may not 
have received any specialist training. For example, implementation of anger 
management programmes and education of nurses in aggression management.
There is evidence that this may have implications for the role of clinical psychology. 
The Scottish Health Advisory Service (SHAS, 1996) in a recent review of this NHS 
Trust identified that staff on Ward A had not had recent training in aggression 
management and recommended that all staff should be trained in aggression 
management. A training strategy is now being developed to educate nurses as trainers 
in the management of aggression, but currently there is no clinical psychology input. 
Clinical psychology could have a role to play, in the analysis of problem situations and 
involvement in individual and group programmes of anger management, as well as 
developing operational policies.
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Predicted Need and Provision For Clinical Psychology
Respondents indicated that they thought there was a significant need to increase the 
actual provision of psychological services on both wards. Indeed SHAS (1996) noted 
that the “in-patient clinical psychology service for the severally mentally ill is 
inadequate and only present in some units, though there are no complaints regarding 
the quality of the service where it is provided”. Although staff predicted that clinical 
psychology services would increase, the estimation of an actual increase of 64% may 
have been a rather generous estimate, as no extra clinical psychology staffing is likely 
to become available on Ward A in the near future.
It is unlikely that such an increase in staffing will occur, partly due to staffing policies 
and funding constraints, but also due to the fact that nation-wide there are not enough 
clinical psychologists to fill current vacancies, never mind future ones. Indeed 
without dramatic changes to clinical training to provide more clinical psychologists 
this is unlikely to change.
Rather than relying on increases in funding, a more cost effective use of clinical 
psychology resources appears to lie in the “consultancy model” (MPAG, 1990). This 
involves utilising level III skills (MAS, 1989) in teaching, training and supervision, 
and putting psychological skills at the disposal of other professions to increase the 
level of psychological skills on the wards as a whole. This could provide the most 
cost effective way of cascading psychological skills to all levels for the benefit of 
patients and staff alike.
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Patient Assessments
The results of assessing patients using the BHS, BAAQ and BIS indicated clinical 
levels of symptomatology that could be amenable to psychological intervention. 
Assessment on the BHS indicated that both wards had at least one patient who scored 
in the severe range, exhibiting extremely negative values about the future and who 
may be a future suicide risk. Six patients assessed on the BAAQ, scored within the 
range that can be interpreted as indicating a fair likelihood of poor anger control, 
which may find expression in physical violence. Highly impulsive subjects as 
measured by the BIS (50% of assessed patients) are reported as more ‘present’ 
orientated and are characterised by a ‘hair trigger’ temper (Barratt, 1994). It was 
notable that even on ward B where there was a psychological service, patients were 
still demonstrating severe symptomatology which may reflect the reality of the limited 
service which psychology could provide.
However these scores do indicate possible areas for psychological intervention on 
both wards. Where hopelessness was indicated, appropriate psychological risk 
management may be to offer the patient therapy i.e. cognitive therapy, utilising the 
BHS as a tool to suggest areas for intervention. The BHS as a repeat assessment 
measure may also be utilised to predict risk of suicide (Beck and Steer, 1993). Where 
aggression and impulsiveness were indicated, appropriate measures may involve 
education of nurses in aggression management as well as possible individual therapy 
or anger management training for patients.
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Methodological Issues
The confidence with which these finding can be interpreted is limited by reservations 
such as bias from retrospective self-report and the relative weighting clinicians can 
give to specific predictors of risk. Further, elements of evidence which support these 
variables as important in predicting risk are based on correlation data, rather than 
casual relationships.
Recommendations
Introducing psychological assessment and psychological therapy to the wards may 
enable patients to focus on gaining confidence in managing their symptoms and could 
help resolve problems prior to discharge and enable some form of effective risk 
management to occur, whilst providing a valuable database for future studies.
It is suggested that there is a need for further evaluation research regarding risk 
management at this hospital. Assessment of patients in this study was limited largely 
by the number of volunteers, but a more extensive survey and profile of relevant 
wards could be facilitated by the use of case note data and the recently introduced 
violent incident recording system. This would enable identification of needs and 
provide a template for future service development.
It is also recommended that the use of pre-, post- and follow up measures of anger, 
impulsiveness and hopelessness are taken from patients, to build individual 
vulnerability profiles to complement existing clinical assessments of risk already in 
place on the wards. For the clinical psychologist who may carry these out, these
18
formal measures will provide an assessment of risk, as well as providing sound 
empirical data for future research and possibly more appropriate utilisation of 
psychological resources.
Conclusions
Clinical psychology compared to most other professions is relatively small and in a 
large body such as the NHS, small professions are often forgotten or neglected. 
However clinical psychology is a discipline with a solid body of research 
demonstrating the clinical efficacy of its approaches to a wide range of problems. 
There is also evidence to show brief psychological interventions can reduce the cost 
of other health services, making savings which are greater than the cost of providing 
psychological services (MAS, 1989). Clinical psychologists need to educate service 
purchasers of the benefits achievable through increasing clinical psychology provision. 
They also need to help other clinical staff develop their knowledge of psychological 
approaches. Coupled with the specialist and consultancy roles of clinical 
psychologists, this could bring immense benefits to staff and patients alike.
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TABLES
Male Female Age range Transfer from 
State Hospital
Patient with 
criminal record
Ward A 5 0 26-47 2 5
Ward B 4 1 29-40 0 0
Table 1: Details o f Participant Sample.
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Nurse Psychiatrist Psychologist OT
D R D R D R D R
Ward A 27 7 3 2 0 0 0 0
Ward B 14 8 2 2 0 0 1 1
Table 2: Professions o f Questionnaire Respondents.
D= Questionnaires distributed.
R= Questionnaires actually returned.
OT= Occupational Therapist (works on both wards).
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Ward A Number of health professionals 
completing rating
Percentage of health
professionals
rating this activity (%)
Assessing IQ 4 44%
Ward B Number of health professionals 
completing rating
Percentage of health
professionals
rating this activity (%)
Assessing IQ 6 54%
Assessing personality 4 36%
Consulting with staff on 
aggression management
4 36%
Education of nurses re. 
aggression
4 36%
Therapeutic work with 
patient’s families
4 36%
Devising and 
implementation of anger 
management programme
4 36%
Completing appropriate 
research
5 45%
Table 3: Activities Rated as Most Appropriate to be Completed by a Clinical 
Psychologist.
Tasks viewed as appropriate for other professions to 
complete
Assessing for brain damage
Facilitating communication between staff and patients
Assessment of psychotic symptomology
Therapeutic work with suicidal risk patients
Assessing client motivation & compliance
Making home visits
Interviewing families
Conducting team building in-service days
Implementing behavioural change programmes
Assessment of patients for rehab
Providing group therapy training i.e. social skills
Assessment of likelihood of harming others
Monitoring of aggression levels on the ward
Assessing suitability for admission/discharge
Acting as patient advocate
Conducting one to one therapy with a patient
Chairing case conferences
Table 4: Tasks Viewed as Appropriate fo r  Other Professions 
to Complete.
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Ward A Number of activities perceived as most 
appropriate to complete
Percentage of activities perceived as 
most appropriate to complete
Nursing 15 63%
Psychiatry 7 29%
Psychology 1 4%
OT 1 4%
Ward B Number of activities perceived as most 
appropriate to complete
Percentage of activities perceived as 
most appropriate to complete
Nursing 10 42%
Psychiatry 7 29%
Psychology 7 29%
OT 1 4%
Table 5: Number o f Activities each Profession is Perceived as Most Appropriate to 
Complete.
0T= Occupational Therapy.
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Ward B Number of health professionals 
completing rating
Percentage of health
professionals
rating this activity (%)
Assessing IQ 4 36%
Therapeutic work with 
patient’s families
3 27%
Table 6: Activities Actually Completed by a Clinical Psychologist on Ward B.
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Tasks which are not completed by clinical psychologists on 
Ward B
Assessing for brain damage
Facilitating communication between staff and patients
Assessment of psychotic symptomology
Therapeutic work with suicidal risk patients
Assessing client motivation and compliance
Making home visits
Interviewing families
Educating nurses re. aggression
Conducting team building in-service days
Undertaking appropriate research
Assessing personality
Assessing patients for rehab
Providing group therapy training i.e. social skills
Assessment of likelihood of harming others
Monitoring aggression levels on the ward
Assessing suitability for admission/discharge
Acting as patient advocate
Chairing case conferences
Devising and implementing anger management programmes 
Consulting with staff members on aggression management 
Conducting one to one therapy with patients 
Implementing behavioural change programmes
Table 7: Tasks Which Are Not Completed by Clinical 
Psychologists on Ward B.
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Ward A Number of activities 
completing
Percentage of activities 
completing
Nursing 19 79%
Psychiatry 4 17%
Psychology 0 0%
OT 1 4%
Ward B Number of activities 
completing
Percentage of activities 
completing
Nursing 17 71%
Psychiatry 4 17%
Psychology 2 8%
OT 1 4%
Table 8: Number o f activities each profession is rated as actually completing.
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Profession Mean projection of increase in staffing 
needed rated on a scale of 1-100
Mean projection of actual staffing 
provision expected rated on a scale of 
1-100
Psychology 85% 64%
Psychiatry 77% 74%
Nursing 57% 58%
OT 48% 59%
Table 9: Staffing Projections o f Ward A and B Combined: Projections o f Need and 
Projections fo r  Actual Involvement for each Profession over the Next 5 Years.
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Number of individuals scoring above cut-off
Assessment measure Ward A n=5 Ward B n=5
BIS 3 2
BHS 1 1
BAAQ 3 2
Total meeting cut-off in 
any category
3 2
Table 10: Individuals Scoring within High Risk Range on Assessment Measures.
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ABSTRACT
Continuous Positive Airway Pressure (CPAP) is the most effective treatment for 
obstructive sleep apnoea. It has been shown to be highly effective in eliminating sleep 
apnoeas and reducing daytime sleepiness. However, it can be cumbersome and 
intrusive, and as a result compliance is often below clinically effective levels. 
Consequently the issue of compliance has become one of crucial importance. 
Multiple factors have been investigated as possible variables in CPAP compliance and 
this review discusses the literature to date.
Recent work has suggested that CPAP treatment may have a beneficial effect upon 
personal relationships for partners of CPAP patients, but no study has investigated the 
impact that the relationship an individual has with their bed partner may have upon 
subsequent compliance. The absence of research in this area is discussed with 
suggestions for future investigation.
Keywords: Obstructive sleep apnoea; continuous positive airway pressure; 
compliance; marital relationships.
35
INTRODUCTION
Obstructive Sleep Apnoea
Obstructive sleep apnoea (OSA) is a common disorder affecting more than 4% of the 
general adult population (1) and more than 25% of the elderly (2). It is defined as 
repetitive episodes of complete (apnoea) or partial (hypopnoea) upper airway 
obstruction during sleep, which result in episodic asphyxia and interruption of the 
normal sleep pattern (3). The chief clinical consequences are excessive daytime 
sleepiness, habitual snoring, nocturnal choking, unrefreshing sleep, nocturnal enuresis, 
inability to concentrate and decreased alertness (4). Polysomnography, which usually 
is required to confirm the presence of OSA or to assess its severity, demonstrates the 
apnoeic events, arterial oxygen desaturation and disturbed sleep architecture of this 
syndrome (5). Neuropsychiatric symptoms have been reported as a consequence of 
OSA (6-9), as have cognitive impairments (10-14), although a clear pattern of deficits 
has not emerged. Clinically relevant consequences of the symptoms of OSA include 
decreased work efficiency, impairment in quality of life and increased risk of 
automobile accidents (15).
CPAP Treatment
The introduction of continuous positive airway pressure (CPAP) administered 
through a nasal mask in 1981 (16) represented an important step in the treatment of
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OSA, tracheostomy having been the previous treatment of choice (17, 18). Acting as 
a pneumatic splint, nasal CPAP secures the patency of anatomically narrowed and 
collapsible airways, restoring unobstructed breathing during sleep. CPAP treatment 
has been shown to be highly effective in eliminating sleep apnoeas and hypopnoeas, 
normalising sleep patterns and reducing daytime sleepiness (19-21). Originally it was 
thought that occasional “treatment holidays” could be taken without too deleterious 
an effect. Subsequent research however, has confirmed the importance of continual 
nightly CPAP use, and that missing one night of CPAP treatment can abruptly lower 
the objective level of daytime alertness even in the absence of subjective worsening 
(22, 23). Thus, the necessity of regular nightly use of CPAP has made the issue of 
treatment compliance one of primary importance. Moreover, not only does non 
compliance have serious implications for individuals (residual daytime somnolence and 
cardiovascular morbidity), it also has serious implications for systems (finance used in 
supporting collective misuse of expensive equipment and staff time) (24).
CPAP is also a “symptomatic” treatment, prescribed for an undetermined period of 
time, and unlikely to result in a cure. Treatment compliance has been shown to be 
compromised where such a lifestyle change is required (25), and where a condition 
(such as sleep apnoea) is chronic, non life threatening and involves long term 
treatment (26). Such failure to comply with the initiation or maintenance of a 
prescribed regimen, especially one of a preventative nature (such as CPAP), is 
characterised as one of today’s major unsolved health problems (27) and is beginning 
to be acknowledged as the most prominent reason for failed therapy (28).
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Consequently this review will examine the literature regarding the nature of 
compliance to CPAP, possible influential factors and areas for future research.
CPAP COMPLIANCE
It is worth noting that reporting within the CPAP literature is compounded by the lack 
of a standard definition o f ‘compliance’, making comparison between studies difficult. 
Krieger and colleagues (29) identified three types of compliance (of which the latter 
two are the most commonly utilised); primary acceptance of CPAP at the stage of 
initial prescription, secondary acceptance of CPAP, measured by the number of 
patients who continue with CPAP after starting and finally the rate at which the 
people who continue with CPAP treatment actually use it.
Subjective assessment o f CPAP compliance
Initial studies of compliance with CPAP were based on self report questionnaires and 
showed quite high levels of use (30-36), where compliance was defined as patients 
who accepted CPAP after initial prescription and continued with treatment. Sanders 
and colleagues (30) analysed the number of nights per week and the fraction of nightly 
sleep time during which the device was used and found an impressive long-term 
compliance rate of 75%. Retrospective analysis by Waldhom (34) indicated that 76% 
of patients who had accepted the initial prescription of CPAP were still using CPAP at
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the time of follow-up. This was supported by a prospective study done by Waldhom 
& Wood in 1993 (37), where using similar parameters, compliance was noted as being 
76%. Since this earlier work various studies have attempted to analyse the 
compliance of patients with treatment and the factors affecting long term use of 
nocturnal ventilation.
Objective Assessment o f CPAP Compliance
To circumvent the difficulties inherent in patients self report studies (social 
desirability, influence of expectation and the limitations of memory), subsequent 
studies investigated compliance by measuring the total time that power is turned on to 
a CPAP unit. These studies (38-40) found compliance rates similar to that in the 
literature reporting subjective use, but this was most likely because patients were 
aware of the time counters, and in some instances patients were asked to report the 
readings from these counters. Subsequently, the first study covertly monitored “mask 
on” time (41). Patients were given CPAP machines that contained a microprocessor 
and monitor that measured actual pressure at the mask (there is an increase in mask 
pressure when the mask is put on). Monitor output was compared to self report at 
follow up. The majority of patients (66%) overestimated their actual use of the CPAP 
machine by 69 ± 110 minutes. Since then subsequent studies have confirmed the 
discrepancy between objective and subjective reporting of CPAP use, averaging 
around one hours difference between the two (15, 42-44, 39), although one study has
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reported that subjective reports of CPAP compliance correlate significantly with 
objective compliance measures (30).
Objective evaluation of CPAP use within the literature is now standard. Research has 
indicated that the mean duration of CPAP use in a night is 5.23 hours (range 3.2-6.9 
hours) (15, 41, 45-48). However research has shown that effective time is about 10% 
less than running time (41). Adjusting average machine “on times” to reflect mask 
“on time” means that the average duration of nightly CPAP use is 4.85 hours (15, 41, 
45-48).
Long term compliance
Long term studies assessing chronically treated patients have generally supported 
higher compliance rates. Krieger and colleagues (29) reported a compliance rate of 
over 85% after seven years (where compliance was defined as patients continuing 
with treatment after initial prescription). A further study (24) reported that patients 
used their CPAP machine for 94% of the monitored period (2 years) at a mean 
effective daily rate of use of 6.9 hours. Subsequent studies have confirmed these 
relatively high rates of use over longer periods of time ( > one year) (32, 43, 44, 49, 
50). Though these figures are impressive, it must be remembered that studies over a 
longer period of time are measuring compliance in a self selecting population, as those 
who have abandoned treatment are not included in the results percentages. Thus 
these studies are documenting treatment compliance in a population who by definition
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are accepting of CPAP as a treatment. This is supported by evidence that rejection of 
CPAP occurs very early in treatment, generally within the first three months of 
treatment (34-36, 39, 46) or even within the first week of therapy (53, 55).
Short term compliance
As a result of most CPAP non compliance commencing within the first three months 
of treatment, studies assessing compliance over a shorter period of time tend to report 
slightly lower and possibly more realistic rates, as they reflect patient drop out from 
treatment. Indeed effective use of CPAP during periods of up to three months may be 
as poor as 50% (51). Kribbs and colleagues (23) reported a mean duration of use of 
4.9 hours (±1.9 hours) and that only 46% of patients met the criteria for regular use 
(using CPAP 4 hours a day on 70% of the days). Other studies (39, 41, 45) have 
supported these findings of poor compliance with short term use of CPAP therapy.
FACTORS THAT INFLUENCE COMPLIANCE
As the therapeutic success rate of CPAP treatment relies on patient acceptance of the 
device, it is consequently of paramount importance to evaluate factors that contribute 
to or undermine compliance. A wide range of variables has been investigated within 
the literature. These have included demographic variables (31, 33, 41, 47) and 
physiological variables such as disease severity (46), body mass index (31, 36, 39, 41,
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42, 45, 52, 53), mean sleep latency time (time it takes an individual to get to sleep) 
(33, 41, 45, 52, 53, 54), respiratory disturbance index (RDI - number of apnoeas and 
hypopnoeas per hour of sleep) (15, 41, 45, 53, 54) and nocturnal oxygen saturations 
(41, 52, 54). Despite this volume of research no single physiological parameter has 
consistently emerged as a predictive factor.
The impact of the CPAP machine itself on compliance has also been investigated (36, 
57) as problems with the machine predominate in reports of non-compliance (15, 30, 
32, 34, 40, 41, 45, 47). Difficulties include mechanical characteristics of the device, 
such as its weight, dimensions, type of CPAP machine (automatic vs. standard CPAP 
(58), claustrophobia (23), noise level and portability (15, 36, 53, 59) and mask 
discomfort (30, 31, 34, 41). Engleman (15) has categorised these problems into three 
areas: nuisance factors (frequent awakening, noise, sore eyes), mask problems (leaky 
mask, mask rubbing) and side effects (dry throat, nasal stuffiness). Subjective CPAP 
use was negatively correlated with nuisance factors and positively related to mask 
problems. A variety of devices have been added to conventional CPAP machines and 
alleged to lead to improved compliance. These include heat/humidification, ramp 
CPAP pressure, bi level CPAP and self adjusting CPAP (57).
Psychological Factors and Compliance
Psychological factors have been minimally investigated and to date there is only one 
study that has investigated the importance of psychological factors in CPAP
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compliance. Edinger and colleagues (60) in a non-randomised prospective study of 
38 men, found that eventual compliers scored lower on the Minnesota Multiphasic 
Personality Inventory (MMPI) Hopelessness and Depression scales prior to treatment 
than did non-compliers. They postulated that non-compliers’ higher MMPI 
Depression scale scores reflected greater negativism which may have underlain their 
non-acceptance of CPAP therapy. By default, Rosenthal and colleagues (55) 
suggested personality characteristics might be the pre-treatment factors that were 
instrumental in determining CPAP compliance after being unable to associate CPAP 
use with any indicators of disease severity.
The lack of examination of psychological factors is surprising considering the amount 
of literature that documents the importance of psychological factors in other chronic 
illnesses which require long term prophylactic treatment. For example many HIV 
patients, despite being relatively asymptomatic, are required to adhere to therapeutic 
regimens for prolonged, often indefinite periods of time. Non compliance in HIV 
patients has been associated with greater depression (61, 62), greater psychological 
distress, emotional disturbance and poor adaptive coping (63). Treatment for 
diabetes is also long term and depends on assumption of responsibility by the patient. 
Low self esteem (64), high anxiety (65), interpersonal conflicts (66) and psychiatric 
illness (67) have all been negatively associated with treatment compliance. Family 
dysfunction (68) and psychological variables (69) have also been implicated in 
compliance with asthmatic therapeutic regimens.
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These data would suggest that psychological variables may have implications for 
patients’ motivation to use CPAP and that investigation of these variables may 
provide avenues to promote CPAP compliance.
Personal relationships and compliance
There has been no study to date of the impact that the psychological health of a 
couple’s relationship may have on CPAP compliance. This is surprising, as an 
individual’s initial presentation for treatment is often at the prompting of a bed partner 
who has been kept awake by snoring, choking and/or restless sleep (70). 
Furthermore, although there are joint benefits to CPAP such as the alleviation of 
snoring, there are also costs. Once treatment has commenced, both partners have to 
tolerate the machine and all its physical disadvantages such as noise and obtrusiveness 
(15). CPAP may also separate partners for sleep and impact heavily upon intimate 
and sexual time together (70). As an individuals bed partner is likely to be one of the 
most influential in a persons life their perception of and adjustment to CPAP is 
possibly an important component of patients’ compliance to treatment. Therefore, the 
impact of CPAP therapy on a partner’s sleep and the relationship with that person 
would seem to be an important component of the assessment of CPAP efficacy and 
subsequent compliance.
This neglect of marital variables is all the more surprising considering research 
indicates that higher marital satisfaction and strong social relationships appear to be
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predictors of compliance and positive health outcomes in a variety of chronic illnesses 
(71, 72) similar to OS A, that require long term prophylactic treatment. Research as 
early as 1967 (73) has found that higher marital satisfaction and good familial support 
systems are positively associated with compliance to a medical treatment regimen. In 
HIV research, lower treatment compliance has been associated with poor 
relationships with partners (74), whereas in comparison, positive relationships have 
been reported to have a beneficial effect on HIV treatment compliance (75). There is 
also a plethora of studies in the diabetic literature describing the positive relationship 
between marital satisfaction and compliance (76-81) and reports that negative or 
upsetting interactions between couples can have severe detrimental effects for 
treatment compliance (82). This has led researchers within the wider health literature 
to suggest that research into compliance issues should shift it’s focus from the patient 
alone to include assessment of the marital relationship and the psychological well­
being of the spouse (76).
CHRONIC ILLNESS AND RELATIONSHIPS
As poor health decreases an individual’s ability to fulfil one’s family role, marital 
relationships are likely to face potential stress and alteration. Hafstrom and Schram 
(83) demonstrated that marital satisfaction was significantly lower for wives with 
chronically ill husbands. This has been widely supported within the health literature 
for both spouses in a variety of chronic illnesses (84-87).
45
However, while the consequences of OSA for the patient are well documented e.g. 
excessive daytime somnolence, snoring, decreased libido, poor concentration, 
impaired memory and fatigue (89); the implications that these symptoms may have for 
patients’ relationships is not. Only 2 studies to date have documented the impact of 
OSA upon relationships and families, although these appear to be consistent with the 
broader health literature. Gall and colleagues (90) have reported that those with OSA 
had poorer family relationships, including marital relationships. Prior to this, 
Cartwright and Knight (91) in a non-randomised study, established the impact of OSA 
upon the marriages of patients. They noted that not only does sleep apnoea separate 
marriage partners for sleep time, but it also severely limits their shared social time due 
to the patient’s inability to sustain evening wakefulness. Reported marital satisfaction, 
of partners was poor, as measured by the Marital Satisfaction Inventory (92), which 
led the authors to conclude that untreated OSA is a source of friction in marriages.
This study highlighted that those who treat OSA patients should be aware that 
partners may also need support or direct help. They may need to be educated about 
the disorder and made part of the treatment team since many of the treatments for 
these patients involve the partner’s participation (e.g. weight control, alcohol 
reduction). In doing so, perhaps some of the strain on a couple’s relationship may be 
alleviated. It also suggests that if symptoms of OSA are impacting on both marital 
partners, then so may the treatment, indicating that perhaps to focus only on how this 
condition affects the patient is somewhat limited.
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Impact o f CPAP on relationships
Little attention has been paid to the effects of CPAP treatment itself upon couples’ 
relationships and only one study to date has investigated this. Kiely and McNicholas 
(70) concluded that bed partners of patients treated by CPAP experienced 
improvements in sleep quality, daytime alertness, mood and quality of life as measured 
by qualitative questions. Through the same measures they also found an improvement 
in couples’ relationships following institution of CPAP therapy, thus indirectly 
supporting the view that untreated OSA is a cause of friction in many relationships, 
(91), and that OSA may be an important factor in motivating the bed partner to 
initially bring the patient to medical attention. However this study was retrospective 
in that patients and bed partners compared subjective impressions of previous status 
(pre CPAP) to their current status (receiving CPAP). Furthermore the assessment 
measures they used were not formally standardised or validated and were composed 
simply of 9 qualitative questions devised by the authors. Further clarification of the 
impact of CPAP on relationships would be desirable by a prospective study utilising 
reliable, validated measures to assess marital satisfaction (93). Support for the 
argument that improvements in marital satisfaction may be attributable to CPAP 
treatment could be provided by the supplementary validated, measurement of known 
outcome variables in CPAP treatment, such as daytime sleepiness (94), subjective 
health status (95) and daily functioning (96).
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CONCLUSIONS
Since the original description of CPAP administered via a nasal air mask for the 
treatment of OSA, it has become the non surgical choice as the most effective 
treatment for this disorder. Treatment with CPAP is highly successful in reducing 
apnoeic episodes during sleep and subsequently improves or resolves clinical 
symptoms of sleep apnoea, but as therapy in almost half of those prescribed CPAP is 
less than optimal, CPAP compliance must receiv^ef continued emphasis. To date, ( 
there does not seem to be a singular disease-related or demographic variable that has 
consistently been identified as affecting compliance with CPAP therapy. However, 
there are factors within the wider health literature, such as marital satisfaction, that 
have been shown to be important in treatment compliance in other chronic illnesses 
which have not been investigated with regard to CPAP treatment. Furthermore, there 
is evidence that marital relationships are important in OSA; patients often present at a 
doctors at the partner’s request due to disturbed sleep and untreated OSA has been 
shown to be a cause of friction between couples. This suggests that marital 
relationships and partners may be influential in CPAP non-compliance, but validated 
research is needed to confirm or disprove it. The fact that positive relationships have 
a positive effect on treatment compliance and poor relationships have a negative effect 
in other chronic illnesses would certainly seem to suggest this. Psychological factors 
may also play an important part in CPAP therapy, as although they have been 
identified in OSA patients, their possible impact on compliance has not as yet been 
fully assessed.
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The sharp decline in CPAP use by those who eventually abandon treatment suggests 
that the explanation for non-compliance to treatment may be antecedent to therapy. 
The application of conceptual models of motivation for health behaviours could 
provide a framework for the identification of characteristics (such as marital 
satisfaction, psychological variables) of those less compliant with CPAP. Without 
understanding of these characteristics of non-compliers, it is unlikely that future 
intervention strategies will be successful.
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SUMMARY
Continuous Positive Airway Pressure (CPAP), administered through a nasal mask is 
the current treatment of choice for obstructive sleep apnoea (OSA). CPAP treatment 
is very effective, but it’s intrusive nature often results in poor compliance. Multiple 
factors have been investigated as possible variables in CPAP compliance, but there has 
been no published study to date evaluating the influence of the psychological health of 
the marital unit upon CPAP compliance. This is surprising considering that once 
treatment is started, both partners have to tolerate the machine and all it’s 
disadvantages for an undetermined period of time. This study will be the first 
evaluation of the relationship between the psychological health of the marital unit and 
CPAP compliance. Individuals (diagnosed as suffering from sleep apnoea) and their 
partners will be assessed with regard to marital satisfaction, sleepiness, daily 
functioning and subjective health status prior to CPAP treatment. Measures will be 
repeated one, three and six months after the commencement of treatment. The study 
will be completed at the National Sleep Laboratory in the Royal Infirmary of 
Edinburgh.
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INTRODUCTION
Obstructive Sleep Apnoea (OSA) is defined as repetitive episodes of complete 
(apnoea) or partial (hypopnoea) upper airway obstruction during sleep which result in 
episodic asphyxia and interruption of the normal sleep pattern (Guilleminault et al, 
1978). The introduction of continuous positive airway pressure (CPAP) administered 
nightly through a nasal mask in 1981 (Sullivan et al, 1981), represented an important 
step in the treatment of this condition, tracheostomy having been the previous 
treatment of choice (Motta et al, 1978).
CPAP treatment has been shown to be highly effective for OSA eliminating sleep 
apnoeas and hypopnoeas, normalising sleep patterns and reducing daytime sleepiness 
(Guilleminault et al, 1993; Issa & Sullivan, 1986). There are problems associated 
with CPAP therapy however, which include claustrophobia (Hoffstein et al, 1992), 
nasal congestion (Sanders et al, 1986), uncomfortable masks and the noise from the 
machine itself (Engleman et al, 1996). In addition CPAP treatment is a ‘symptomatic’ 
treatment, prescribed for an undetermined period of time, and unlikely to result in a 
cure. Compliance has been shown to be compromised where such a lifestyle change is 
required (Kaplan, 1990) and where a condition (such as sleep apnoea) is chronic, non 
life threatening and involves long term treatment (Claydon & Efron, 1994).
Perhaps, in part because of these difficulties, compliance with CPAP is often 
incomplete. Patient drop-out can be as high as 30% (Krieger, 1992) and nightly
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usage rates are often below clinically effective levels. This has serious implications for 
both individuals (residual daytime somnolence and cardiovascular morbidity) and 
systems (finance used in supporting collective misuse of expensive equipment and 
staff time) (Fleury, 1996).
Consequently, it is of paramount importance to evaluate factors that contribute to or 
undermine CPAP compliance. While physical (Rauscher et al, 1991; Rolfe et al, 
1991; Sanders, 1986) and psychological (Edinger et al, 1994) factors have been 
identified in individuals compliance, there has been no study to date of the influence 
that the psychological health of a couple’s relationship may have on CPAP 
compliance, even though this is a treatment regime that imposes on both partners.
Furthermore, while there is a comprehensive literature describing the impact of spouse 
illness and treatment upon marital relations (Krausz, 1988; Carter & Carter, 1994; 
Kester et al, 1988), and noted impairments in patients’ quality of life prior to starting 
CPAP treatment (Flemons, 1997), little attention to date has been paid to the impact 
that CPAP treatment itself may have upon couples’ relationships. This is surprising as 
although there are joint benefits to CPAP such as the alleviation of snoring, there are 
also costs. CPAP may separate partners for sleep time and impact heavily upon 
intimate and sexual time together (Kiely & McNicholas, 1997).
This study will be, to the author’s knowledge, the first evaluation of the relationship 
between CPAP compliance and the psychological functioning of a couples’ 
relationship.
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HYPOTHESES
It is postulated that:
Hypothesis 1: There will be a positive correlation between marital satisfaction at 
baseline and subsequent CPAP compliance in the CPAP group.
Hypothesis 2: CPAP patients will show improvement in their marital satisfaction 
scores from baseline to follow-up. There will be no change in marital satisfaction 
scores for the control group.
Hypothesis 3: CPAP patients will show positive changes in measures of health 
outcome; daytime sleepiness (Epworth Sleepiness Scale), subjective health status (36 
Item Short Form Health Survey Questionnaire) and daily functioning (Functional 
Outcomes of Sleep Questionnaire). There will be no change in the control group.
Hypothesis 4: CPAP patients will show a positive correlation between changes in 
marital satisfaction and other outcome measures (from baseline to follow-up) and 
treatment compliance.
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PLAN OF INVESTIGATION 
PATIENTS
Power statistics were performed to calculate the size of experimental group required. 
CPAP Patients, n=44.
Control Group, n=15.
Inclusion Criteria
Individuals will be invited to participate if they meet all of the following criteria:
1. Diagnosis of OSA
2. Currently involved in a relationship whether married or unmarried of at least 1 
years duration.
3. Currently living with partner.
4. Are on the waiting list to commence CPAP treatment.
5. Are able to be contacted by phone.
Exclusion Criteria
Individuals will not be invited to participate if they meet any of the following criteria:
1. Additional medical diagnoses that may confound the experimental data.
2. Co-morbid psychiatric disorder.
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Recruitment and Consent o f  Patients
Patients currently on the waiting list for CPAP treatment at the Royal Infirmary in 
Edinburgh will be identified from existing case records. All patients will have been 
diagnosed by standard all-night clinical polysomnography as meeting the criteria for 
sleep apnoea of the obstructive type (Bornstein, 1982).
CPAP patients: For the experimental condition patients will be within 2 months of 
starting CPAP treatment. Patients will receive an introductory letter, written 
information about the study and a consent form (Appendices 3.1, 3.2 and 3.3 
respectively). At the same time their partners will be sent an introductory letter, 
written information and a consent form (Appendices 3.4, 3.5 and 3.6 respectively).
Control Patients: For the control condition patients will be contacted 8 months prior 
to them starting CPAP treatment (to allow for 6 months of measurement whilst on the 
waiting list). Patients will receive an introductory letter, written information about the 
study (Appendices 3.7 and 3.8 respectively), and a consent form (Appendix 3.3). At 
the same time their partners will be sent an introductory letter, written information 
(Appendices 3.9 and 3.10 respectively) and a consent form (Appendix 3.6).
Patients and their partners in both groups will be informed their participation (or lack 
of it) will not affect treatment, that they may withdraw at any time and that all 
information will be treated in strictest confidence. A letter will be sent to patients’ 
GPs on receiving both partner’s consent forms (Appendix 3.11).
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MEASURES
ENRICH Marital Satisfaction Scale.
The ENRICH (evaluation and nurturing relationship issues, communication and 
happiness) Marital Satisfaction (EMS) Scale (Fowers & Olsen, 1993) provides a brief 
measure of marital satisfaction suitable for research purposes. It offers a dyadic 
positive couple agreement (PCA) score (the percentage of items on which both 
partners evaluate their relationship positively), as well as an individual measure of 
marital satisfaction for each partner. Each of the Marital Satisfaction items represents 
one of the 10 most important dimensions of marital satisfaction (Fournier et al, 1983). 
Reliability and validity are established (Fowers & Olsen, 1993).
Functional Outcomes o f Sleep Questionnaire.
The Functional Outcomes of Sleep Questionnaire (FOSQ) (Weaver et al, 1997) is a 
self report functional status instrument that specifically targets the ways in which sleep 
disorders impair daily activities. The FOSQ has been demonstrated to be sensitive to 
how sleep disorders affect patients’ abilities to conduct normal activities and is a valid 
outcome measure in disorders of sleep (Weaver et al, 1997). There are five subscales 
on the FOSQ and one Summary Score. Good validity and test-retest reliability have 
been demonstrated (Weaver et al, 1997).
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36 Item Short Form Health Survey Questionnaire.
The 36 Item Short Form Health Survey Questionnaire (SF 36) (Jenkinson, 1996) is a 
generic measure of subjective health status. It measures 8 multi-item dimensions. 
Two summary scores can also be calculated of physical (Physical Component 
Summary-PCS) and emotional well being (Mental Component Summary-MCS) which 
replicate the 8 dimensions, aiding interpretation and reducing the likelihood of chance 
findings due to multiple comparisons (Ware et al, 1993). It has been shown to have 
good internal consistency, construct validity and test/re-test reliability (Brazier et al, 
1992; Garret et al, 1993). Furthermore, it has demonstrated efficacy as an outcome 
measure in sleep disorders and in treatment with CPAP (Smith & Shneerson, 1995). 
Normative data for an adult British population are available (Jenkinson et al, 1993).
Epworth Sleepiness Scale.
The Epworth Sleepiness Scale (ESS) (Johns, 1991) is a simple, 8 item self­
administered questionnaire that is capable of distinguishing patients suffering from 
OSA from individuals with no sleep disorder. The ESS provides a general 
measurement of a patient’s daytime sleepiness and has also been shown to clinically 
demonstrate response to treatment with CPAP in patients with OSA (Hardinge et al, 
1995). Test-retest reliability, internal consistency (Johns, 1992) and validity 
(Hardinge et al, 1995) of the ESS have been demonstrated.
Six Qualitative Questions.
Five qualitative questions regarding patients’ marital relationship will be included in 
the questionnaire pack. Four of the questions require that patients give a numerical
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answer, the other is a simple yes or no. A sixth single question regarding CPAP use 
will also be included (Appendix 3.12).
Partners in both groups will be asked to complete the EMS Scale and the 6 qualitative 
questions only.
Compliance
Objective compliance with treatment will be assessed by use of the built-in time 
counter on the machine which records the total time the unit is switched on. CPAP 
patients will be contacted by phone and asked to report the readings from the CPAP 
machine themselves at three time points; 1, 3 and 6 months into CPAP therapy. 
Follow up appointments at the National Sleep Laboratory after 6 months will allow 
technicians to check the time counters and confirm readings. The mean rate of use, 
utilised as an index of objective compliance, is calculated by dividing the number of 
hours the machine is on by the number of days of use.
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DESIGN & PROCEDURE
This is represented in Figure 1.
Stage 1
Following approval from Ethics, all patients shall be contacted by post prior to 
commencing CPAP therapy. Patients will be sent an information form explaining the 
study is investigating difficulties experienced from CPAP use, a consent form and 
questionnaire measures. The initial postal contact will also request partners 
participation. Questionnaire measures for their completion will also be included in the 
pack, along with a consent form.
Stages 2-4
CPAP patients and their partners will be contacted at 1, 3 and 6 months after the start 
of CPAP treatment for repeat completion of outcome measures. Control patients on 
the waiting list for CPAP therapy will be contacted at the same time intervals. This 
design will provide a measure of relationship variables and compliance at 1, 3 and 6 
months into CPAP treatment.
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Stage of Process Procedure Involved
STAGE 1
Patients and their partners give consent. ESS, FOSQ, 
SF36, EMS & qualitative questions administered to both 
groups of patients. Partners contacted at the same time 
and complete EMS and qualitative questions. Following 
this CPAP therapy is commenced for the CPAP group. 
Control group remain on the waiting list.
STAGE 2
One month into therapy, CPAP and control patients and 
their partners complete all outcome measures again. 
CPAP patients are contacted over the phone and asked 
to give reading from CPAP machine.
4
CPAP and control group contacted again after 3 and 6
months. Patients and partners both complete all
STAGES 3-4 outcome measures again. CPAP patients are contacted
by phone and asked to report reading from the CPAP
machine.
Figure 1: Experimental Procedure o f Study.
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SETTING
Patients will be completing questionnaires in the privacy of their own homes. 
Demographic data will be obtained from the National Sleep Laboratory, Royal 
Infirmary of Edinburgh.
DATA ANALYSIS
Experimental data and basic demographic details will be stored on a password 
protected database in coded form. This information will be held at Gartnavel Royal 
Hospital in an alarmed and locked room within the computing department.
Should the data demonstrate normal distributions and homogeneity of variance, 
parametric tests will be utilised in preference to non-parametric tests. Descriptive 
statistics will be used to determine means and the standard deviation for group data, 
as well as examining distribution and continuity. If parametric tests are indicated, data 
will be examined with two way analysis of variance (ANOVA) to control for 
experiment-wide error when comparing patients over multiple scores. If non- 
parametric tests are indicated, Mann Whitney will indicate differences in outcome 
measures between groups. T-tests (related) or Wilcoxin statistical tests will determine 
degree of change within groups. The relationship between compliance and marital 
satisfaction will be examined by correlational analysis (Pearson or Spearman).
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PRACTICAL APPLICATIONS:
1. Identification of factors that may help to predict compliance with CPAP machines, 
leading to a reduction in both personal cost for individuals and economic cost for 
the NHS.
2. Identification of difficulties within relationships that are caused by CPAP treatment 
that may be remedied by psychological intervention at the appropriate stage.
3. Support for the role of the psychologist in managing a condition which currently is 
treated primarily by medical professionals but which would likely benefit from a 
clinical psychologist’s intervention.
TIMESCALES
Data Collection till March 1999.
Data Analysis and write up from March 1999 till July 1999.
ETHICAL APPROVAL
Ethical approval will be sought from Lothian Research Ethics Committee.
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Explanatory Statement
The following is a statement explaining the discrepancy between the research proposal
and the research paper.
This study initially intended to assess patients at 3 time points, 1,3, and 6 months into 
CPAP therapy. Ethics required that patients should give consent by post before 
partners could be contacted. When partners had also consented by post, only then 
could the questionnaire packs be sent out. This resulted in a much longer recruitment 
period than had initially been anticipated and so patients were only followed up at one 
time point, 3 months into therapy. Three months was chosen as an appropriate time 
point, as of those studies that have documented when patients have stopped using 
CPAP, all have found that this occurred within the first three months of treatment 
(Krieger, 1992; Reeves-Hoche et al, 1994).
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ABSTRACT
To obtain objective evidence of the pattern of CPAP use and it’s relationship with 
marital satisfaction, information was gathered from the National Sleep Laboratory in 
Edinburgh. Sixty-nine patients and their partners comprised the two groups of the 
study; 44 of whom were due to start CPAP within 2 months, and 25 had at least a 6 
month wait. Primary outcome measures were the ENRICH Marital Satisfaction 
Scale, the 36-Item Short Form Health Survey Questionnaire, the Functional 
Outcomes of Sleep Questionnaire, the Epworth Sleepiness Scale and 6 qualitative 
questions. Patients completed all measures on enrolling into the study. Partners 
completed the ENRICH Marital Satisfaction Scale and the 6 qualitative questions. 
Three months later, all participants re-completed the measures again and compliance 
readings were taken from the CPAP machines. No significant baseline correlates of 
compliance were found. However, couples receiving CPAP perceived their marital 
satisfaction as significantly improved compared to controls. CPAP couples also 
demonstrated improved daytime sleepiness, subjective health status and daily 
functioning. Controls demonstrated decrements in marital satisfaction and all other 
outcome measures over the 3 month period. No significant relationship between 
changes in marital satisfaction over time and treatment compliance was found. 
Partner marital satisfaction was highlighted as a potentially important variable in 
treatment compliance that warrants further investigation, in accordance with the 
broader health literature.
Keywords: continuous positive airway pressure therapy; obstructive sleep apnoea; 
treatment compliance; marital satisfaction.
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INTRODUCTION
The use of nasal continuous positive airway pressure (CPAP) administered through a 
nasal mask (1) is recognised to be the treatment of choice for obstructive sleep 
apnoea (OSA). Originally it was thought that occasional “treatment holidays” could 
be taken without too deleterious an effect. Subsequent research however has 
confirmed the importance of continual nightly CPAP use, and that missing one night 
of CPAP treatment can abruptly lower the objective level of daytime alertness even in 
the absence of subjective worsening (2,3). Once using CPAP however, patient drop 
out can be high, sometimes as much as 30% (4), nightly usage rates vary (5, 6, 7, 8, 9, 
10) and are often below clinically effective levels (10). As therapeutic success rate 
relies on patient acceptance of the device, it is of paramount importance to evaluate 
factors that may contribute to or undermine compliance. Much has been made of the 
physical side effects of CPAP (10, 11, 12, 13, 14, 15, 16) as adversely impacting its 
use, but there has been no study to date of the influence that the psychological health 
of the marital unit may have on CPAP compliance. This is surprising, since a patient’s 
initial presentation for assessment of symptoms indicative of OSA is often at the 
prompting of a bed partner (17), who has been kept awake by snoring, choking and/or 
restless sleep. Furthermore, once treatment has commenced, both partners have to 
tolerate the machine and all it’s physical disadvantages. As an individual’s bed partner 
is likely to be one of the most influential in a persons life, the quality of the 
relationship with this person is possibly an important component of patient 
compliance to CPAP. Indeed research within the wider health literature supports the 
importance of the marital unit in treatment compliance (18, 19, 20, 21).
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While there is a comprehensive literature describing the impact of other spouse 
illnesses and treatment upon marital relationships (22, 23, 24, 25) there is a notable 
paucity of information of the effects of sleep apnoea (14) or CPAP treatment (15) 
upon marital relationships. Cartwright and Knight (17) described untreated OSA as a 
cause of friction in relationships and highlighted partners’ need for support or direct 
help. Subsequently, a cross-sectional, retrospective study (26) reported that bed 
partners of OSA patients treated with CPAP experienced improvement in sleep 
quality, daytime alertness, mood, quality of life and subjective rating of the marital 
relationship. These data suggest that CPAP therapy leads to improvement in 
subjective perceptions of marital satisfaction, in addition to improvements that have 
already been noted; improved alertness (14), amelioration of sleep architecture (27) 
and improved subjective health (28).
The primary purpose of the present study was to determine firstly whether there was a 
relationship between measured marital satisfaction at initiation of treatment and 
subsequent CPAP compliance. Secondly, it sought to ascertain if over time there was 
an improvement in subjective marital satisfaction with CPAP treatment. It was 
intended to ascertain whether marital satisfaction is an important variable in CPAP 
compliance and also to clarify the utility of marital satisfaction as an outcome variable.
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HYPOTHESES
The hypotheses of the study were:
Hypothesis 1: There would be a positive correlation between marital satisfaction at 
baseline and subsequent CPAP compliance in the CPAP group.
Hypothesis 2: CPAP patients would show improvement in their marital satisfaction 
scores from baseline to follow-up. There would be no change in marital satisfaction 
scores for the control group.
Hypothesis 3: CPAP patients would show positive changes in measures of health 
outcome; daytime sleepiness (Epworth Sleepiness Scale), subjective health status (36 
Item Short Form Health Survey Questionnaire) and daily functioning (Functional 
Outcomes of Sleep Questionnaire). There would be no change in the control group.
Hypothesis 4: CPAP patients would show a positive correlation between changes in 
marital satisfaction and other outcome measures (from baseline to follow-up) and 
treatment compliance.
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METHOD
Sample
A total of 149 patients from the Scottish National Sleep Laboratory, Royal Infirmary 
of Edinburgh requiring positive-pressure therapy for the treatment of OSA were 
initially contacted. Of these 104 were due to shortly start CPAP therapy, the 
remaining 45 had at least a 6 month wait and served as controls. Control patients on 
the waiting list were not untreated, conservative therapy consisted of advice on losing 
weight, avoiding evening alcohol etc. In total 44 of the original CPAP patients and 25 
of the control patients completed both stages of the study. This gave a response rate 
of around 38% for the CPAP group and 55% for the control group. Reasons for 
exclusion are detailed in Appendix 4.2.
To participate in this study patients had to be living with their partner but not 
necessarily married. The protocol was approved by Lothian Research Ethics 
Committee and informed consent was obtained from patients and their partners. At 
no time was data obtained used to alter clinical care. All patients had undergone 
diagnostic polysomnography to confirm OSA (apnoea-hypopnoea index [AHI] >5/h) 
and were within 2 to 6 months of being prescribed CPAP therapy.
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Outcome Measures
Upon enrolment, each patient and their partner were sent a questionnaire pack for 
completion. The patients’ pack consisted of:
ENRICH Marital Satisfaction Scale.
The ENRICH (evaluation and nurturing relationship issues, communication and 
happiness) Marital Satisfaction (EMS) Scale (29) provides a brief measure of marital 
satisfaction suitable for research purposes. It offers a dyadic positive couple 
agreement (PC A) score (the percentage of items on which both partners evaluate their 
relationship positively) as well as an individual measure of marital satisfaction for each 
partner. Each of the Marital Satisfaction items (Appendix 4.3) represents one of the 
10 most important dimensions of marital satisfaction (30). Reliability and validity are 
established (29).
Functional Outcomes o f Sleep Questionnaire.
The Functional Outcomes of Sleep Questionnaire (FOSQ) (31) is a self report 
functional status instrument that specifically targets the ways in which sleep disorders 
impair daily activities. The FOSQ has been demonstrated to be sensitive to how sleep 
disorders affect patients’ abilities to conduct normal activities and is a valid outcome 
measure in disorders of sleep (31). There are five subscales on the FOSQ and one 
summary score (Appendix 4.4). Good validity and test-retest reliability have been 
demonstrated (31).
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36 Item Short Form Health Survey Questionnaire.
The 36 Item Short Form Health Survey Questionnaire (SF 36) (32) is a generic 
measure of subjective health status. It measures 8 multi-item dimensions (Appendix 
4.5). Two summary scores can be calculated of physical (Physical Component 
Summary - PCS) and emotional well being (Mental Component Summary - MCS) 
which replicate the 8 dimensions, aiding interpretation and reducing the likelihood of 
chance findings due to multiple comparisons (33). It has been shown to have good 
internal consistency, construct validity and test/re-test reliability (34, 35) and has 
demonstrated efficacy as an outcome measure in sleep disorders and in treatment with 
CPAP (36). Normative data for an adult British population are now available (37).
Epworth Sleepiness Scale.
The Epworth Sleepiness Scale (ESS) is a simple, 8 item self-administered 
questionnaire that is capable of distinguishing patients suffering from OSA from 
individuals with no sleep disorder. The ESS provides a general measurement of a 
patient’s daytime sleepiness (38) and has also been shown to clinically demonstrate 
response to treatment with CPAP in patients with OSA (39). Test-retest reliability, 
internal consistency (40) and validity (39) of the ESS have been demonstrated.
Six Qualitative Questions.
Five qualitative questions regarding patients’ marital relationship were also included in 
the questionnaire pack. A sixth single question regarding CPAP use was also 
included (Appendix 4.6).
Partners were asked to complete the EMS Scale and the 6 qualitative questions only.
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Objective Compliance
Objective compliance with treatment was assessed by use of the built-in time counter 
on the machine that accumulates the time the power is on in the unit. Follow up 
appointments at 3 months allowed technicians to check the time counters. In the 
absence of appointments, patients were contacted by phone and asked to report the 
readings from the machines themselves. The mean rate of use utilised as an index of 
objective compliance, was calculated by dividing the number of hours the machine had 
been on, by the number of days of use.
Analysis
All analyses were performed using SPSS/PC+ (version 7.5.1). Descriptive statistics 
were used to determine means and the standard deviation for group data, as well as 
examining distribution and continuity. Kurtosis and skewness were also calculated. 
Examination of data revealed relatively normal distributions for the primary measures 
(Appendix 4.7.1 - 4.7.7) as did the kurtosis/skewness indices. Consequently, data 
were examined parametrically with two way analysis of variance (ANOVA) to control 
for experiment-wide error when comparing patients over multiple scores. T-tests 
were also performed on each variable to compare the groups at baseline and at 
follow-up to clarify any significant results. The 6 qualitative questions were examined
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using non-parametric analyses, due to their skewed distribution. A correlation 
analysis was performed with the Spearman coefficient, due to the non normal 
distribution of compliance and AHI in the sample populations. Alpha levels were set 
conservatively at .01 (two tailed) to prevent the occurrence of a Type 1 error.
RESULTS
Baseline Measures o f CPAP and control groups
The baseline patient characteristics of both CPAP and control patients are described in 
Table 1. There were no significant differences between the respective clinical groups 
in age, AHI or gender. There was also no significant difference between groups at 
baseline on any of the outcome measures (Appendix 4.8). Mean rate of compliance in 
the CPAP group following treatment was 4.41 hours per night. This degree of CPAP 
compliance is similar to that found in previous studies (12).
Insert Table 1 here
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Hypothesis 1: There would be a positive correlation between marital satisfaction at 
baseline and subsequent CPAP compliance in the CPAP group.
In order to examine the association between baseline marital satisfaction and AHI and 
compliance, a Spearman correlation matrix was computed (Table 2). AHI was 
included as it has been a reliable predictor of compliance in other studies (41). There 
were no significant baseline correlates of compliance, including marital satisfaction or 
AHI.
Insert Table 2 here
To further investigate the relationship between baseline marital satisfaction and 
compliance, CPAP patients were subdivided into three groups (low, medium and high 
marital satisfaction): firstly on the basis of one third of patients in each group (by 
number) and secondly based on the range of marital satisfaction scores (i.e. scores 
within one of 3 ranges; 25-45, 45-65, 65-85). One way non-parametric analysis was 
performed using Kruskal-Wallis ANOVA due to the small sample size and to reduce 
the risk of Type 1 error. The same was then repeated for the partners of the CPAP 
patients. Results are given in Table 3.
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Insert Table 3 here
Examination of Table 3 reveals that the 3 groups were significantly different when 
split by number. Mann Whitney comparisons (Appendix 4.9) were conducted as post 
hoc tests and these confirm that it was the group reporting intermediate marital 
satisfaction that was reporting significantly lower compliance compared to the other 
two groups. It can also be seen from Table 3 that when CPAP patients were divided 
by marital satisfaction scores, the group reporting intermediate marital satisfaction still 
had lower rates of compliance than the other two groups, although this effect was not 
statistically significant. It is also evident from Table 3 that there was no significant 
difference in patient compliance for the 3 groups of partners, which is confirmed by 
further analyses (Appendix 4.9). Scatterplots of the distribution of patient and partner 
marital satisfaction scores and compliance are displayed in Figures 1 and 2 
respectively.
Insert Figures 1 and 2 here
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Hypothesis 2: CPAP patients would show improvement in their marital satisfaction 
scores from baseline to follow-up. There would be no change in marital satisfaction 
scores fo r  the control group.
The means for the 2 groups at baseline and 3 month follow-up for the battery of 
outcome measures are presented in Table 4. The results from factorial ANOVA 
comprising between group, within time and interaction of group by time effects are 
also given in Table 4.
Insert Table 4 here
Significant group by time interactions were found for patient marital satisfaction, 
partner marital satisfaction and positive couple agreement, indicating that couples 
receiving CPAP perceived their marital satisfaction as significantly improved 
compared to the control couples (Figures 3, 4, & 5). Most of the qualitative 
questions showed a ceiling effect (Appendix 4.10). There was however a significant 
drop in the number of arguments reported by both partners (Question 4) in the CPAP 
group (Appendix 4.10). Further analyses (Appendix 4.11) confirmed that the CPAP 
group were reporting significantly less arguments than the control group.
Control group scores did not remain stable as predicted but deteriorated, showing a 
decrement in marital satisfaction for both partners and in positive couple agreement.
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This is supported by the significant increase in the number of arguments reported by 
partners in this group (Appendix 4.10).
Insert Figures 3, 4 & 5 here
Figures 3, 4 and 5 suggested that the significant difference over time was due to 
improvements in follow-up scores for the CPAP group. Independent t-tests between 
groups confirmed that significant effects are accounted for by treatment differences at 
follow-up (rangep  =.000 to .003) and not at baseline (Appendix 4.12).
Hypothesis 3: CPAP patients would show positive changes in measures o f health 
outcome; daytime sleepiness (ESS), subjective health status (SF 36) and daily 
functioning (FOSQ). There would be no change in the control group.
Examination of Table 4 also reveals significant group by time interactions were found 
for all health outcome measures and indicates that CPAP patients improved 
significantly more on health outcome measures than the control group. Mean scores 
on the Physical and Mental components of the SF 36 were well below the normative 
mean of 50 (37) for both groups at baseline, but at follow-up, the scores for the 
CPAP group were within normal range. Both groups also demonstrated excessive 
sleepiness at baseline as measured on the ESS, but at follow-up, the ESS score of the 
CPAP group had fallen significantly, into normal range (40). Data from the FOSQ
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summary score also indicated adverse health status at baseline. Significant 
improvements were evident with the institution of CPAP therapy resulting in a 
summary score more consistent with that of normal individuals (31). Again as with 
the marital satisfaction scores, control group scores did not remain stable but 
deteriorated. This suggests that patients perceived their physical health as 
deteriorating more the longer they remained untreated. Figures 6 to 9 suggested that 
the significant difference over time was due to the CPAP group’s improvement in 
follow-up scores. Independent t-tests between groups confirmed that significant 
effects were accounted for by treatment differences at follow-up (all p  =.000) and not 
at baseline (Appendix 4.12).
Insert Figures 6, 7, 8 & 9 here
Hypothesis 4: CPAP patients would show a positive correlation between changes in 
marital satisfaction and other outcome measures (from baseline to follow-up) and 
treatment compliance.
In order to consider the association between changes in marital satisfaction, 
compliance and other outcome measures, a Spearman correlation matrix was 
computed between the change score of variables and compliance (Table 5).
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Insert Table 5 here
First, inspection of the table suggests that the relationship between compliance and 
marital satisfaction score was stronger as perceived by partners, although this 
correlation was not statistically significant (r =0.307, p  =0.043). Second, compliance 
was strongly associated with the FOSQ summary score (r =.570, p  =.000), indicating 
compliance and clinical improvement related to quality of life. Compliance was also 
strongly associated with the Mental Component score of the SF 36 but not with the 
Physical Component score. This suggests that CPAP treatment was having a greater 
effect on the emotional domains that compose the Mental Component score, such as 
social functioning, emotional role, energy and vitality. Third, compliance was 
strongly related to improvement in ESS scores, in other words greater compliance did 
lead to less subjective sleepiness. Fourth, marital satisfaction also reflected health 
outcomes. In particular, there was a strong inverse correlation between patient (r =- 
.399, p  =.007) and partner (r =-.617, p  =.000) marital satisfaction and ESS scores, 
indicating that perceived marital satisfaction improved as sleepiness scores decreased. 
Finally, the FOSQ summary score (r =-.754, p  =.000) and SF 36 Mental component 
score (r =-.578, p  =.000) were significantly related to ESS scores, indicating that self- 
reported daytime sleepiness and mental health may contribute to the functional 
impairments associated with sleep apnoea.
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DISCUSSION
Initial hypotheses will be considered with regard to results, before discussion of the 
implications of findings. This section will finish with a critique of the experimental 
method employed and suggestions for future steps in research.
The first hypothesis was that baseline measures of marital satisfaction would be 
related to CPAP compliance. It was initially anticipated that greater baseline marital 
satisfaction would be associated with greater compliance, and lower satisfaction 
would be associated with lower compliance. However, this first hypothesis was not 
strongly supported. Consideration of the scatterplot in Figures 1 and 2 revealed that 
there was not a linear relationship between the 2 variables. Further analyses on sub­
groups of patients with higher or lower marital satisfaction, elucidated that both 
groups had significantly higher compliance rates than those who rated their marital 
satisfaction at the intermediate level. However, this did depend upon how the sub­
groups were formed, as when they were split by marital satisfaction scores, there was 
no difference between sub-groups (although this involved a group with a very small 
sample size of 8). Furthermore, the pattern of difference between sub-groups was not 
confirmed by analyses of partner’s scores. However, if this is a true effect it may 
mean that high marital satisfaction and by implication good marriages, provide the 
support necessary to maintain good compliance. Conversely, perceived low marital 
satisfaction, possibly as a result of difficulties caused by OSA (sleepiness, irritability), 
may motivate a patient to use their CPAP machine effectively, perhaps seeing it as a
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solution to a problem. Individuals who report medium marital satisfaction may not be 
as motivated nor have such good support. Analysis with a bigger sample may clarify 
the ambiguity present here.
The second hypothesis of this study was that CPAP patients would show 
improvement in marital satisfaction scores from baseline to follow-up, whereas 
controls would not. The findings indicated that CPAP was more effective than 
conservative treatment on a waiting list, in improving marital satisfaction in patients 
and their partners. These data suggest that the beneficial effects of eliminating 
snoring and allowing both partners to get a more restful sleep and possibly reductions 
in excessive daytime sleepiness, outweigh any possible deleterious effect from the 
noise or obtrusiveness of the CPAP machine.
Contrary to expectations, the control group did not remain stable, as control patient 
and partner marital satisfaction actually decreased, which is confirmed by the fact that 
the number of arguments reported also increased. This supports research evidence 
that untreated OSA is a source of friction in marriages (17) and that with limited 
energy as a result of OSA, relationship responsibilities may take a low priority. As 
partner marital satisfaction also decreased for this group, this suggests that there 
should perhaps be more direct involvement and support of partners in the treatment of 
OSA, particularly since other studies have shown that OSA can also have negative 
implications for partners e.g. increased anxiety and depression (17).
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The third hypothesis was confirmed in that CPAP treatment led to a statistically 
significant reduction in sleepiness and improvement in subjective health status and 
daily functioning compared to the control group. However, the use of statistical 
significance tests to evaluate treatment effects is limited (42) in that it provides no 
information regarding clinical significance; the extent to which functioning of the 
CPAP group had actually been returned to a normal range and whether it made a real 
practical difference in peoples’ lives. With regard to the former, the initial ESS and 
SF 36 scores of both groups were similar to scores obtained by patients classified as 
suffering from “severe” OSA (40), but when treated with CPAP for 3 months, the 
ESS and SF 36 scores of the CPAP group fell significantly, into the normal range 
previously described for middle-aged non-snoring subjects (38, 43). Summary scores 
on the FOSQ fell to marginally outwith normal range (31). With regard to the latter, 
evidence of real differences in peoples’ lives was provided by comments that patients 
gave following their 3 months of CPAP therapy:
“If I had been told one year ago how much better my quality of life would be
after I started using the machine I would never have believed it was possible”.
“Makes 100% difference”.
“The CPAP machine is very good and improved my sleep pattern”.
“I feel a lot better and far more energetic”.
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In addition to generating changes in areas associated with daytime hypersomnolence, 
it appears that CPAP has restored to sleep apnoeic patients that which is most 
meaningful to them; the ability to once again engage in social activities, get a good 
nights sleep, fulfil daily roles and be as active as their peers.
Controls in contrast, demonstrated decrement in functioning on all of the above 
measures in the 3 month time period. Actual waiting lists for CPAP treatment are 
much longer than 3 months, up to a year as a result of funding in the UK being 
withdrawn or severely limited (44) following a negative review (45). If the data 
reported in this study regarding the deterioration in controls’ health status and daily 
functioning represents a true effect, a wait of up to 1 year may have serious 
implications for the psychological morbidity of patients’ relationships and their health.
A relationship was found between increases in partner’s marital satisfaction and 
intervening CPAP compliance although this was not statistically significant (CPAP has 
previously been associated with improvements in quality of life for partners, 26), 
partially supporting the fourth hypothesis. This would suggest that the more 
compliant an individual was with CPAP therapy, the greater the improvement in 
partners’ marital satisfaction or vice versa. Independent data would support the 
former, that untreated OSA was a cause of friction in these relationships, which CPAP 
then resolved (26).
No relationship was found between changes in patient marital satisfaction and 
compliance. One possible explanation for this could be that partner marital
satisfaction may be a more important contributory variable in relation to CPAP 
compliance. An alternative explanation is that there was no relationship between 
changes in patient marital satisfaction and CPAP compliance. The fact that increases 
in partner marital satisfaction were correlated with compliance would suggest the 
former, especially since patient marital satisfaction was related to all health outcomes, 
(which do relate to compliance), apart from the Physical component of the SF 36. 
These data highlight the potential importance of partners in the treatment of OSA. 
They suggest that partners may be able to give useful insight into the impact of CPAP 
therapy on the lives of patients and their families and that it may be important to 
include partners in any intervention designed to improve compliance confirming 
research from the general health literature (21). It may also mean making changes to 
how patients are dealt with in sleep clinics and encouraging more active participation 
of partners in treatment.
CPAP compliance was however, associated with patient change scores on the FOSQ, 
ESS and Mental component of the SF 36, which indicated that better compliance was 
associated with reduced daytime sleepiness, improved subjective health and daily 
functioning.
Assessment of marital satisfaction with more than one marital measure would 
strengthen findings, allow cross validation and clarification of whether compliance is 
associated with marital satisfaction at baseline or throughout treatment. A 
behavioural element to this assessment would also eliminate some of the bias that is 
inherent in self reporting. Patients are normally brought in for a day of assessment
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prior to commencing CPAP; requesting that both partners attend would perhaps allow 
behavioural observation, thus facilitating objective measurement, as well as potentially 
improving compliance by involving partners. Psychopathology may also have 
influenced marital satisfaction scores. This could be controlled for by validated 
measurement of variables such as anxiety and depression. Furthermore, depression 
has been shown to influence CPAP compliance (46) and should be accounted for by 
assessment in future studies.
Sampling issues are also evident in this study; unequal sample sizes and self selecting 
participants. To better study complex variables such as marital satisfaction and their 
interaction with treatment, future study should involve equal sized groups with a 
much larger sample size. Deterioration in control scores may have been due to 
demand characteristics in that the control group may have utilised this survey as an 
opportunity to express their dissatisfaction with waiting time, which would have been 
exacerbated at follow-up 3 months later. It would be desirable to control for this with 
either placebo treatment (44) or validated measurement of demand characteristics. 
Although data used was self-report, it has been suggested that the “bottom line” for 
the appraisal of health care delivery is the patient’s perspective of how this care has 
affected their daily life (47). Therefore, from the patient’s viewpoint, CPAP seems to 
be highly effective in returning them to a normal life. Furthermore objective 
measures, such as mean sleep latency time (MSLT) are often time consuming and 
cumbersome. Some compliance data was self-report, but the majority was objective, 
and compliance rates found herein are similar to that previously noted (12). 
Furthermore, reports of CPAP compliance have been found to correlate significantly
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with objective compliance measures such as the counters used on the machines in this 
study (48).
These methodological difficulties suggest some future directions for research, namely 
a randomised study with more comprehensive assessment of marital quality, possibly 
with behavioural measures as noted earlier. The fact that a relationship has been 
shown to exist between marital satisfaction and CPAP compliance and other health 
outcome variables is enough to suggest the importance of further research in this area.
CONCLUSIONS
In summary, the findings of this study indicate CPAP is not only associated with 
improvement in marital satisfaction and health outcome measures over the course of 
treatment but actually appears to prevent deterioration in relationships. Partner 
marital satisfaction has been highlighted as particularly important, and there is a need 
to incorporate this into future research. Clinicians involved in the management of 
OSA may find these data of practical clinical use when advising patients with OSA on 
the potential impact of CPAP on their quality of life.
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TABLES AND FIGURES
Characteristic CPAP n=44 Controls n=25
Mean SD Mean SD
Age (years) 49 9.5 51 10.3
AHI 45 39.9 39 15.7
n % n %
Female 10 23 6 24
Male 34 77 19 76
Table 1: Characteristics o f Patients Treated with CPAP Therapy and Controls. 
AHI - Apnoea Hypopnoea Index.
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Figure 1 .Scatterplot of the Distribution of Patient Marital Satisfaction Scores.
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Figure 2 .Scatterplot of the Distribution of Partner Marital Satisfaction Scores.
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SINGLE CLINICAL CASE RESEARCH STUDY ABSTRACT 1
A substantial literature now exists that indicates that cognitive-behaviour therapy is 
effective for a wide range of psychological problems (Hawton et al. 1989). However, 
it is only recently that cognitive behaviour therapists have considered people with 
learning disabilities as suitable clients for this particular approach. The present paper 
explores some of the reasons for the lack of use of cognitive behaviour therapy in the 
field of learning disabilities and reports on it’s adaptation for people with a learning 
disability. One case study of an individual with a mild learning disability illustrates the 
clinical applications. All the elements of cognitive behaviour therapy were maintained 
but simplified. Improvements were seen on the Zung Anxiety Inventory, the weekly 
frequency of panic attacks and in the daily monitoring of anxious feelings.
Keywords: Cognitive behaviour therapy; learning disability; panic disorder.
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SINGLE CLINICAL CASE RESEARCH STUDY ABSTRACT 2
This single case research study presents clinical psychological intervention for a 
gentleman with Chronic Fatigue Syndrome. Illness attributions are believed to play a 
crucial role in perpetuating CFS, however, in this single case research study, causal 
illness attributions were challenged with only minimal beneficial clinical effect on 
mood or thought content. Recent evidence suggests that physical illness attributions 
may be less important in determining outcome in CFS than previously thought 
(Heijmans, 1998), and that good outcome is instead associated with change in 
avoidance behaviour and related beliefs (Deale et al. 1998). Hypotheses for the 
limited success of this case are discussed in addition to methodological criticisms of 
the study.
Keywords: Chronic fatigue syndrome; cognitive behaviour therapy; illness 
attributions.
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SINGLE CLINICAL CASE RESEARCH STUDY ABSTRACT 3
Background: In the last 20 years there has been much debate about whether shallow 
water diving (<40m) may lead to long term neuropsychological sequelae. 
Hypothesis: The aim of the study was to investigate possible neuropsychological 
effects from repeated diving in a single case clinical research study. Method: A 42 
year old man with a 17 year diving history was assessed using a neuropsychological 
test battery. Results: Neuropsychological test results indicated difficulty in auditory 
memory, memoiy for faces and retention problems. Deficits in executive functioning 
were also evident. Results indicated slight effects in choice reaction time. 
Conclusions: The main finding in this single case study of a non-saturation amateur 
diver supports deficits noted in previous studies of extensive non-saturation diving. In 
addition, mild deficits in executive functioning are reported for the first time. 
Neuroleptic medication may be a confounding variable in this case and it is suggested 
that further investigation is warranted.
Keywords: non-saturation diving; neuropsychological function; executive
functioning.
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APPENDIX 1.2
Questionnaire 1
Please tick which discipline (where applicable) you think is most appropriate to carry out each 
activity on the ward. Please leave blank if no discipline carries out a particular role on the ward.
Activity Psychiatrist Nurse Psychologist OT
Assessing patient for brain damage
Assessing patient for rehab
Assessing IQ
Assessing client motivation & 
compliance
Assessing personality
Implementing behavioural change 
programme
Conducting one to one therapy with 
patient
Conducting team building/ in- 
service days
Providing group therapy/ training 
i.e social skills
Consulting with staff members on 
aggression management
Making home visits
Interviewing families
Assessing suitability for 
admissison/discharge
Acting as patient advocate
Chairing case conferences
Undertaking appropriate research
Monitoring aggression levls on the 
ward
Therapeutic work with suicidal risk 
patients
Assessment of likelihood of 
harming others
Facilitating communication 
between staff and patient
Therapeutic work with patient’s 
families
Devising & implementation of 
anger management programmes
Assessment of psychotic 
symptomology
Education of nurses re.aggression
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APPENDIX 1.3
Questionnaire 2
Please tick which discipline (where applicable) actually has primary responsibility for each activity 
on the ward. Please leave blank if no discipline carries out a particular role on the ward.
Activity Psychiatrist Nurse Psychologist OT
Assessing patient for brain damage
Assessing patient for rehab
Assessing IQ
Assessing client motivation & 
compliance
Assessing personality
Implementing behavioural change 
programme
Conducting one to one therapy with 
patient
Conducting team building/ in- 
service days
Providing group therapy/ training 
i.e social skills
Consulting with staff members on 
aggression management
Making home visits
Interviewing families
Assessing suitability for 
admissison/discharge
Acting as patient advocate
Chairing case conferences
Undertaking appropriate research
Monitoring aggression levls on the 
ward
Therapeutic work with suicidal risk 
patients
Assessment of likelihood of 
harming others
Facilitating communication 
between staff and patient
Therapeutic work with patient’s 
families
Devising & implementation of 
anger management programmes
Assessment of psychotic 
symptomology
Education of nurses re.aggression
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APPENDIX 1.4
Visual Analogue Scales
Please mark your response on the scale at what you feel to be the most appropriate 
point:
In the next five years how do you see the need for a Clinical Psychologist changing?
Large Decrease Large Increase
In the next five years how do you see the actual involvement of Clinical Psychology?
Decreasing Increasing
In the next five years how do you see the need for a Psychiatrist changing?
Large Decrease Large Increase
In the next five years how do you see the actual involvement of Psychiatry?
Decreasing Increasing
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APPENDIX 1.4 cont..
Please mark your response on the scale at what you feel to be the most appropriate 
point:
In the next five years how do you see the need for an Occupational Therapist 
changing?
Large Decrease Large Increase
In the next five years how do you see the actual involvement of Occupational 
Therapy?
Decreasing Increasing
In the next five years how do you see the need for a Nurse changing?
Large Decrease Large Increase
In the next five years how do you see the actual involvement of Nurses?
Decreasing Increasing
THANKYOU FOR YOUR HELP
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APPENDIX 3.1
CPAP Patient Letter
Dear
The department of Psychological Medicine, University of Glasgow, and the National 
Sleep Laboratory at the Royal Infirmary, Edinburgh are currently undertaking a study 
to investigate the effects of CPAP treatment upon patient’s lives and the difficulties it 
may present. We would like to request you and your partners participation, which 
will help to improve our understanding and as a result help other individuals who 
suffer from this disorder.
Enclosed with this letter are:
1. An information sheet which explains what the study is about and what would be 
involved.
2. A consent form for you to complete should you decide to participate in this study. 
This consent also requests permission to contact your partner, so that they may be 
asked for their participation in this study.
3. A FREEPOST addressed envelope for you to return the completed consent form. 
(No stamp required)
Participation in this study is completely voluntary, your decision will in no way 
affect your ongoing or future treatment, and you may choose to withdraw at 
any time, with no implications. Full confidentiality will be maintained throughout. 
If you decide to participate in this study, your GP and any other physician involved in 
your present care will be informed to let them know what the study involves. I f  you 
decide not to participate, could you please return the consent form stating this, 
otherwise i f  I  do not hear from you, I  may contact you by post again to clarify 
whether you wish to participate.
We hope that you will be interested in taking part in this study.
Yours sincerely,
Theresa McFadyen
Trainee Clinical Psychologist
Professor Colin Espie
Consultant Clinical Psychologist
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APPENDIX 3.2
CPAP Patient Information Sheet.
I would like to ask for your help in a study investigating the effects of sleep apnoea 
and Continuous Positive Airway Pressure (CPAP) treatment on patients’ and their 
partners lives. This study is being conducted by myself, Theresa McFadyen, a 
psychologist in postgraduate clinical training at the University of Glasgow, under the 
supervision of Professor Colin Espie, Consultant Clinical Psychologist. Please take 
your time to read this sheet which gives an outline of the study, and feel free to 
contact me with any questions. Please note that any treatment undertaken at the 
present time or in the future will not be influenced or changed in any way as a 
result of your decision. If you agree to participate in this research, you may 
withdraw at any time without any prejudice to your treatment.
Using a CPAP machine is one of the most effective treatments for sleep apnoea. 
However making such changes to the way you sleep is very difficult, plus there are 
other problems such as mask discomfort, the noise of the CPAP machine etc. This 
study aims to look at the difficulties involved in using CPAP machines, both for you 
and your partner.
Your participation in this study would involve completing a very short questionnaire 
(about your sleep difficulties and how they affect you and your partner) which will 
take around 15 minutes to complete. If you do decide to participate, I will request 
permission to contact your partner. Participation of your partner would involve 
completing a similar shorter questionnaire which would take 5-10 minutes to 
complete. If you and your partner do decide to participate in this study, you will be 
contacted again in around 3 months, and asked to complete the questionnaire once 
more. I f  you decide not to participate could you please return the consent form  
stating this, otherwise i f  I  do not hear from you, I  may contact you by post again to 
clarify whether you wish to participate.
The results of this work will be strictly confidential and used only to help us 
establish particular difficulties for CPAP users and their partners. With a better 
knowledge of what the specific difficulties are and their impact upon patient’s lives we 
can improve the treatment and support that is provided to CPAP users and their 
partners in the future.
If you would like to speak to me regarding any queries you may have or to discuss 
any issues further, you can contact me at the Department of Psychological Medicine 
at Gartnavel Royal Hospital on 0141 211 3920. Alternatively if you wish to speak to 
someone independent of the study, you may contact Mr Paul Fleming at the same 
number.
Thankyou for taking the time to read this.
Theresa McFadyen 
Trainee Clinical Psychologist
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APPENDIX 3.3
Patient Consent Form
I agree to participate in this study
I have read this consent form and the patient information sheet
I understand that I am under no obligation to take part in this study and that a 
decision not to participate will not alter any treatment that I would normally receive.
I understand that I have the right to withdraw from this study at any stage and that to 
do so will not effect any treatment.
I understand that this is non therapeutic research from which I cannot expect to derive 
any benefit.
Signature of Participant
Name of participant and partner (Please print in block capitals)
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APPENDIX 3.4
CPAP Partner Letter
Dear
The department of Psychological Medicine, University of Glasgow, and the National 
Sleep Laboratory at the Royal Infirmary, Edinburgh are currently undertaking a study 
to investigate the effects of CPAP treatment upon patient’s lives and the difficulties it 
may present. Your partner has already consented to participate and now we would 
like to request your participation in this study, which will help to improve our 
understanding and as a result help other individuals who suffer from sleep apnoea.
Enclosed with this letter are:
1. An information sheet which explains what the study is about and what would be 
involved.
2. A consent form for you to complete should you decide to participate in this study.
3. A FREEPOST addressed envelope for you to return the completed consent form. 
(No stamp required)
Participation in this study is completely voluntary, your decision will in no way 
effect your partner’s ongoing or future treatment, and you may choose to 
withdraw at any time with no implications. Full confidentiality will be maintained 
throughout. On receipt of your consent form I will send out questionnaires to both 
you and your partner. I f  you decide not to participate could you please return the 
consent form stating this, otherwise i f  I  do not hear from you, I  may contact you by 
post again to clarify whether you wish to participate.
We hope that you will be interested in taking part in this study.
Yours sincerely,
Theresa McFadyen
Trainee Clinical Psychologist
Professor Colin Espie
Consultant Clinical Psychologist
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APPENDIX 3.5
CPAP Partner Information Sheet
I would like to ask for your help in a study investigating the effects of sleep apnoea 
and Continuous Positive Airway Pressure (CPAP) treatment on patients and their 
partners lives. This study is being conducted by myself, Theresa McFadyen, a 
psychologist in postgraduate clinical training at the University of Glasgow, under the 
supervision of Professor Colin Espie, Consultant Clinical Psychologist. Please take 
your time to read this sheet which gives an outline of the study, and feel free to 
contact me with any questions. Please note that any treatment undertaken by 
your partner at the present time or in the future will not be influenced or 
changed in any way as a result of your decision. If you agree to participate in 
this research, you may withdraw at any time without any prejudice to your 
partners treatment.
Using a CPAP machine is one of the most effective treatments for sleep apnoea. 
However making such changes to the way you sleep is very difficult, and not just for 
the patient but also for their partner. This study aims to look at the difficulties 
involved in using CPAP machines, both for the patient and for their partner.
Your participation in this study would involve completing a very short questionnaire, 
which will take around 5-10 minutes to complete. If you do decide to participate, you 
will be contacted again in around 3 months, and asked to complete the questionnaire 
once more. I f  you decide not to participate could you please return the consent form  
stating this, otherwise i f  I  do not hear from you, I  may contact you by post again to 
clarify whether you wish to participate.
The results of this work will be strictly confidential and used only to help us 
establish particular difficulties for CPAP users and their partners. With a better 
knowledge of what the specific difficulties are and their impact upon patient’s lives we 
can improve the treatment and support that is provided to CPAP users and their 
partners in the future.
If you would like to speak to me regarding any queries you may have or to discuss 
any issues further, you can contact me at the Department of Psychological Medicine 
at Gartnavel Royal Hospital on 0141 211 3920. Alternatively if you wish to speak to 
someone independent of the study, you may contact Mr Paul Fleming at the same 
number.
Thankyou for taking the time to read this.
Theresa McFadyen
Trainee Clinical Psychologist
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APPENDIX 3.6
Partner Consent Form
I agree to participate in this study
I have read this consent form and the partner information sheet
I understand that I am under no obligation to take part in this study and that a 
decision not to participate will not alter any treatment that my partner would normally 
receive.
I understand that I have the right to withdraw from this study at any stage and that to 
do so will not effect any treatment my partner receives.
I understand that this is non therapeutic research from which I cannot expect to derive 
any benefit.
Signature of Participant
Name of participant and partner (Please print in block capitals)
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APPENDIX 3.7
Control Patient Letter
Dear
The Department of Psychological Medicine, University of Glasgow, and the National 
Sleep Laboratory at the Royal Infirmary, Edinburgh are currently undertaking a study 
to investigate the effects of CPAP treatment upon patient’s lives and the difficulties it 
may present. As part of this study we are assessing the effect that having to wait a 
long time before commencing CPAP treatment has upon couples. To do this we are 
contacting individuals such as yourself who have a significant wait before 
commencing CPAP treatment. We would like to request your participation in this 
study, which will help to improve our understanding and as a result help other 
individuals who suffer from sleep apnoea.
Enclosed with this letter are:
1. An information sheet which explains what the study is about and what would be 
involved.
2. A consent form for you to complete should you decide to participate in this study. 
This consent also requests permission to contact your partner, so that they may be 
asked for their participation in this study.
3. A FREEPOST addressed envelope for you to return the completed consent form. 
(No stamp required)
Participation in this study is completely voluntary, your decision will in no way 
effect your ongoing or future treatment, and you may choose to withdraw at any 
time with no implications. Full confidentiality will be maintained throughout. If 
you decide to participate in this study, your GP and any other physician involved in 
your present care will be informed to let them know what the study involves. I f  you 
decide not to participate, could you please return the consent form stating this, 
otherwise i f  I  do not hear from you, I  may contact you again to clarify whether you 
wish to participate.
On receipt of your consent form I will send out questionnaires to both you and your 
partner.
We hope that you will be interested in taking part in this study.
Yours sincerely,
Theresa McFadyen Professor Colin Espie
Trainee Clinical Psychologist Consultant Clinical Psychologist
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APPENDIX 3.8
Control Patient Information Sheet
I would like to ask for your help in a study investigating the effects of sleep apnoea 
and Continuous Positive Airway Pressure (CPAP) treatment on patient’s and their 
partners lives. This study is being conducted by myself, Theresa McFadyen, a 
psychologist in postgraduate clinical training at the University of Glasgow, under the 
supervision of Professor Colin Espie, consultant Clinical Psychologist. Please take 
your time to read this sheet which gives an outline of the study, and feel free to 
contact me with any questions. Please note that any treatment undertaken by 
yourself at the present time or in the future will not be influenced or changed in 
any way as a result of your decision. If you agree to participate in this research, 
you may withdraw at any time without any prejudice to your treatment.
We are undertaking a study to investigate the effects that CPAP treatment has upon 
patient’s lives. However, as you will know there is a long wait fo r  CPAP treatment, 
which can have serious repercussions for some individuals, i.e. having to stop 
driving until you receive your CPAP machine. So as part o f this study we are 
investigating the effect that having to wait so long fo r  a CPAP machine has upon 
couples and individuals lives.
Your participation in this study would involve completing a very short questionnaire 
(about your sleep difficulties and how they affect you and your partner) which will 
take around 15 minutes to complete. If you do decide to participate, I will request 
permission to contact your partner. Participation of your partner, would involve 
completing a similar shorter questionnaire, which would take 5-10 minutes to 
complete. If you and your partner do decide to participate in this study, you will be 
contacted again in around 3 months, and asked to complete the questionnaires once 
more. I f  you decide not to participate could you please return the consent form  
stating this, otherwise i f  I  do not hear from you, I  may contact you by post again to 
clarify whether you wish to participate.
The results of this work will be strictly confidential and used only to help us 
establish particular difficulties for CPAP users and their partners. With a better 
knowledge of what the specific difficulties are and their impact upon patient’s lives we 
can improve the treatment and support that is provided to CPAP users and their 
partners in the future.
If you would like to speak to me regarding any queries you may have or to discuss 
any issues further, you can contact me at the Department of Psychological Medicine 
at Gartnavel Royal Hospital on 0141 211 3920. Alternatively if you wish to speak to 
someone independent of the study, you may contact Mr Paul Fleming at the same 
number.
Thankyou for taking the time to read this.
Theresa McFadyen, Trainee Clinical Psychologist
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APPENDIX 3.9
Control Partner Letter
Dear
The department of Psychological Medicine, University of Glasgow, and the National 
Sleep Laboratory at the Royal Infirmary, Edinburgh are currently undertaking a study 
to investigate the effects of CPAP treatment upon patient’s lives and the difficulties it 
may present.
As part of this study we are assessing the effect that having to wait a long time before 
commencing CPAP treatment has upon couples. To do this we are contacting 
individuals such as your partner who have a significant wait before commencing 
CPAP treatment. Your partner has already consented to participate and now we 
would like to request your participation in this study, which will help to improve our 
understanding and as a result help other individuals who suffer from sleep apnoea.
Enclosed with this letter are:
1. An information sheet which explains what the study is about and what would be 
involved.
2. A consent form for you to complete should you decide to participate in this study.
3. A FREEPOST addressed envelope for you to return the completed consent form. 
(No stamp required)
Participation in this study is completely voluntary, your decision will in no way 
effect your partner’s ongoing or future treatment, and you may choose to 
withdraw at any time with no implications. Full confidentiality will be maintained 
throughout. On receipt of your consent form I will send out questionnaires to both 
you and your partner.
We hope that you will be interested in taking part in this study.
Yours sincerely,
Theresa McFadyen
Trainee Clinical Psychologist
Professor Colin Espie 
Consultant Clinical Psychologist
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APPENDIX 3.10
Control Partner Information Sheet
I would like to ask for your help in a study investigating the effects of sleep apnoea 
and Continuous Positive Airway Pressure (CPAP) treatment on patients and their 
partners lives. This study is being conducted by myself, Theresa McFadyen, a 
psychologist in postgraduate clinical training at the University of Glasgow, under the 
supervision of Professor Colin Espie, consultant Clinical Psychologist. Please take 
your time to read this sheet which gives an outline of the study, and feel free to 
contact me with any questions. Please note that any treatment undertaken by 
your partner at the present time or in the future will not be influenced or 
changed in any way as a result of your decision. If you agree to participate in 
this research, you may withdraw at any time without any prejudice to your 
partners treatment.
As you will know there is a long wait for CPAP treatment. So as part of this study 
we are investigating the effect that having to wait so long for a CPAP machine has 
upon couples and individuals lives. Using a CPAP machine is one of the most 
effective treatments for sleep apnoea. However making such changes to the way you 
sleep is very difficult, and not just for the patient but also for their partner. This study 
aims to look at the difficulties involved in using CPAP machines, both for the patient 
using the machine and for their partner.
Your participation in this study would involve completing a very short questionnaire, 
which will take around 5-10 minutes to complete. If you do decide to participate, you 
will be contacted again in around 3 months, and asked to complete the questionnaire 
once more. I f  you decide not to participate could you please return the consent form  
stating this, otherwise i f  I  do not hear from you, I  may contact you by post again to 
clarify whether you wish to participate.
The results of this work will be strictly confidential and used only to help us 
establish particular difficulties for CPAP users and their partners. With a better 
knowledge of what the specific difficulties are and their impact upon patient’s lives we 
can improve the treatment and support that is provided to CPAP users and their 
partners in the future.
If you would like to speak to me regarding any queries you may have or to discuss 
any issues further, you can contact me at the Department of Psychological Medicine 
at Gartnavel Royal Hospital on 0141 211 3920. Alternatively if you wish to speak to 
someone independent of the study, you may contact Mr Paul Fleming at the same 
number.
Thankyou for taking the time to read this.
Theresa McFadyen 
Trainee Clinical Psychologist
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APPENDIX 3.11
GP Letter
Dear Dr.
Re. Name 
D O B  
Address
The above named patient has agreed to take part in a research study that is being 
carried out in the department of Psychological Medicine, Gartnavel Royal Hospital, 
Glasgow in conjunction with the National Sleep Laboratory, Royal Infirmary, 
Edinburgh. The research is titled; Continuous Positive Airway Pressure (CPAP) 
Treatment, personal relationships and compliance: A Preliminary Investigation. 
I am writing to inform you of you patients involvement and what the study consists 
of.
The study is to investigate the impact that CPAP treatment has on patients lives, with 
particular reference to their marital relationships. Many studies have looked at the 
physical and neuropsychological effects of CPAP treatment but none have 
investigated the impact that this intrusive treatment may have on peoples 
relationships. We also hope to elucidate whether there is a relationship between 
continued compliance with CPAP treatment and marital quality.
Your patient and their partner will be asked to complete several validated 
questionnaire measures just prior to, and possibly during the first 6 months of their 
CPAP treatment/of their partners CPAP treatment. No side effects, distress or 
discomfort are likely to result from taking part in this research. The results of this 
work will be strictly confidential and used only to help us establish the difficulties 
associated with CPAP use and help us to decide how best to help patients with similar 
difficulties in the future.
If you would like further information regarding this project, please do not hesitate to 
contact m eon0141211 3920.
Yours sincerely
Theresa Me Fadyen, Trainee Clinical Psychologist
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APPENDIX 3.12
Qualitative Questions.
1. How many nights in the past week, including today have you slept together in the 
same room?
2. How many times in the past week including today did you have a cuddle/hug?
3. How many times in the past week including today have you sat down to eat you 
evening meal together?
4. How many times in the past week including today have you strongly disagreed 
with your partner?
5. How many times in the past week (your partner) used the CPAP machine for a 
minimum of 4 hours per night?
6. Have you ever considered separation or divorce in the past year?
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Appendix 4.2
Reasons fo r  Exclusion o f CPAP and Control Patients.
REASON FOR EXCLUSION CPAP
n=104
CONTROL
n=45
TOTAL
n=149
Patient failed to return consent 
form
16 4 20
Partner failed to return consent 
form
5 2 7
Patient declined to participate 12 5 17
Partner declined to participate 1 0 1
First set of questionnaires not 
returned
10 7 17
Second set of questionnaires not 
returned
9 2 11
Patient prescribed alternative 
treatment to CPAP
2 0 2
Patient no longer living with a 
partner
5 0 5
Final Sample 44 25 69
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APPENDIX 4.3
Dimensions o f the ENRICH Marital Satisfaction (EMS) Scale.
Personality Issues 
Equalitarian Roles 
Communication 
Conflict Resolution 
Financial Management 
Leisure Activities 
Sexual Relationship 
Children & Marriage 
Family & Friends 
Religious Orientation
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APPENDIX 4.4
Subscales o f the Functional Outcomes o f Sleep Questionnaire (FOSQ).
Activity Level 
Vigilance 
Intimacy & Sexual Relationships 
General Productivity 
Social Outcome 
Summary Score
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APPENDIX 4.5
Dimensions o f the 36 Item Short Form Health Survey Questionnaire (SF 36).
Physical Composite Sub-Scales:
Physical Functioning 
Role Physical 
Bodily Pain 
General Health Perception
Mental Composite Sub-Scales:
Energy/Vitality 
Social Functioning 
Role Emotional 
Mental Health
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APPENDIX 4.6
Qualitative Questions.
1. How many nights in the past week, including today have you slept together in the 
same room?
2. How many times in the past week including today did you have a cuddle/hug?
3. How many times in the past week including today have you sat down to eat you 
evening meal together?
4. How many times in the past week including today have you strongly disagreed 
with your partner?
5. How many times in the past week (your partner) used the CPAP machine for a 
minimum of 4 hours per night?
6. Have you ever considered separation or divorce in the past year?
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APPENDIX 4.7.1
25.0 35.0 45.0 55.0 65.0 75.0 85.0
30.0 40.0 50.0 60.0 70.0 80.0
Patient Marital Satisfaction
Std. Dev =14.04 
Mean = 56.1 
N = 69.00
Distribution of Patient Marital Satisfaction Scores
APPENDIX 4.7.2
20.0 30.0 40.0 50.0 60.0 70.0 80.0
25.0 35.0 45.0 55.0 65.0 75.0 85.0
Partner Marital Satisfaction
Distribution of Partner Marital Satisfaction Scores
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APPENDIX 4.7.3
Std. Dev = 20.11 
Mean = 66.8 
N = 69.00
20.0 40.0 60.0 80.0 100.0
30.0 50.0 70.0 90.0
Positive Couple Agreement
Distribution of Positive Couple Agreement Scores
Fr
eq
ue
nc
y
165
APPENDIX 4.7.4
■o &-0 -& 0  &yo-& o &-0 -& 0  &-0 -& 0  &-o
SF 36 Physical Component
Distribution of SF 36 Physical Component Scores
APPENDIX 4.7.5
Std. Dev = 8.85 
Mean = 41.7 
N = 69.00
25.0 30.0 35.0 40.0 45.0 50.0 55.0 60.0 65.0 
27.5 32.5 37.5 42.5 47.5 52.5 57.5 62.5
SF 36 Mental Component
Distribution of SF 36 Mental Component Scores
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APPENDIX 4.7.6
Std. Dev = 2.46 
Mean = 9.55 
N = 69.00
FOSQ Summary Score 
Distribution o f FOSQ Summary Scores
APPENDIX 4.7.7
Std. Dev = 4.40 
Mean = 14.9 
N = 69.00
Epworth
Distribution of Epworth Sleepiness Scale Scores
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APPENDIX 4.11
Mann Whitney Comparisons Between Groups fo r  the 6 Qualitative Questions
Patients
Question U Z P
1 415.5 -2.06 .03
2 403.0 -2.03 .04
3 518.5 - .56 .57
4 234.5 -4.02 .00
5 50.0 -7.05 .00
6 537.5 - .75 .45
Partners
1 415.5 -2.06 .03
2 403.0 -2.03 .04
3 518.5 - .56 .57
4 234.5 -4.02 .00
5 50.0 -7.05 .00
6 537.5 - .75 .45
Fo
llo
w-
up
 
M
ea
n 
(S
tan
da
rd
 
de
via
tio
n)
 
Sc
or
es
 o
n 
Ou
tco
me
 M
ea
su
re
s 
in 
CP
AP
 
Pa
tie
nt
s 
an
d 
Co
nt
ro
ls.
O
o
o
co
o
o
o
o
O
O
o
o
o
©
o
o
©
O
O
©
r -
00
NO
m
o
cn
NO
(O
NO 
00 1—H
NO
N"
NO
ON
NO
o
CO
CO
NO
o
ON
NO
NO1
C
on
tr
ol
 
n
=
2
5
P
co
r--
ON
t"-l-H
1—H
N-
00
oo
o
K
CN
NO
N;
00
r-H
NO
ol-H
00
00
CN
Tf
o
Tf
cCNJa>
S
m
no
NO
N"
NO
["•
NO
O
o
CN
NO
NO
o
NO
cn
CO
N"
NO
CO
o
00
00
r -
CN
NO
C
PA
P 
n
=
4
4
Q
CO
cn
On
no
NO
NOr—■<
CNr -
NOr" <
NO
ON
ON
CNr-H
ON
NO
TT
CN
1—H
CN
NO
§
s
ON
NO
ON
(N
O
NO
o
NO
CNr -
Tf
cn
00
CO
00
o
NO
NO
On
CN
oo
oo
<D
1
‘S
>
CO
s
+-•ca>
c3
Ph
CO
s
<5
G
t :Cj
PH
<
U
£
pH
NO
Cn
U-t
CO
H
i
NO
CO
pH
CO
baj
3
CO
a
CO
O
Ph
CO
C/3
w
